
==== Front
ACS OmegaACS OmegaaoacsodfACS Omega2470-1343American Chemical Society 3146048510.1021/acsomega.9b01960ArticleConstruction of Dispiro-Indenone Scaffolds via Domino
Cycloaddition Reactions of α,β-Unsaturated Aldimines with
2-Arylidene-1,3-indenediones and 2,2′-(Arylmethylene)bis(1,3-indenediones) Yang Wen-Juan Fang Hui-Lin Sun Jing Yan Chao-Guo *College of Chemistry & Chemical
Engineering, Yangzhou University, Yangzhou 225002, China* E-mail: cgyan@yzu.edu.cn.
Fax: (+86) 514-87975531.07 08 2019 20 08 2019 4 8 13553 13569 29 06 2019 25 07 2019 Copyright © 2019 American Chemical
Society2019American Chemical
SocietyThis is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.

The catalyst-free domino reaction
of α,β-unsaturated N-alkyl or N-arylaldimines with two molecules
of 2-arylidene-1,3-indanediones in dry acetonitrile resulted in polysubstituted
spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridines] in moderate to good yields and with high diastereoselectivity.
The reaction mechanism included sequential aza/oxa-Diels–Alder
reactions via both endo-transition states. On the other hand, the
catalyst-free domino reaction of α,β-unsaturated N-arylaldimines with 2,2′-(arylmethylene)bis(1,3-indenediones)
afforded the mixed diastereoisomeric dispiro[indene-2,1′-cyclohexane-3′,2″-indene]
derivatives in satisfactory yields. The reaction mechanism of this
formal [3 + 3] cycloaddition was believed to proceed with sequential
nucleophilic 1,4-/1,2-additions.

document-id-old-9ao9b01960document-id-new-14ao-2019-019605ccc-price
==== Body
1 Introduction
Indanone-containing
heterocycles are one of the important heterocyclic
scaffolds present in various alkaloids and possessing a broad array
of biological functions.1,2 For example, coleophomone
D existed in a state of flux between different isomeric forms and
possessed antifungal action and the ability to inhibit the serine
protease enzyme and heart chymase.3 4-Azafluorenone
and its derivatives exhibit cytotoxic, phosphodiesterase inhibitory,
coronary dilating, and calcium modulating activities as well as antimicrobial
and antituberculosis agents.4 Typically,
indenopyridone NSC 314622 serving as a lead compound for the evolution
of anticance agents targeting topoisomerase I.5 A series of spirocyclic ketones with bi/terphenyls are potential
leads for development as new anticancer agents and chemical probes
to study signaling networks in neoplastic cells.6 Tricyclic 2,3-dicyano indanopyrazinone acts as an efficient
nonquinone oxidoreductase (NQO1) substrate and may be a new option
for the treatment of NQO1-overexpresssing drug-resistant lung cancer
(Figure 1).7 On the other hand, some indanone-containing polymers
were widely employed in the various materials such as nonlinear optical,
organic photovoltaics, and semiconductors.8

Figure 1 Some
indanone-containing heterocycles with biological property.

Because of the important biological activities they exhibit,
significant
synthetic effects have been devoted to the synthesis of indanone-containing
heterocycles.9,10 For constructing diverse indanone-containing
polycyclic systems, the readily available 1,3-indanedione was regarded
as an active substrate because it has three contiguous electrophilic
and nucleophilic reactive sites.11−13 On the other hand, easily
prepared 2-arylidene-1,3-indanediones are typical 1,3-dipolarophiles
and dienophiles. 2-Arylidene-1,3-indanediones have been widely employed
in many Michael addition, condensation reaction, Diels–Alder
reaction, cyclization reaction, as well as domino multicomponent reactions.14−18 Recently, we have found that a domino aza-/oxa-Diels–Alder
reaction of α,β-unsaturated N-arylaldimines
with 5-arylidene-1,3-dimethylbarbituric acids resulted in polycyclic
spiro[pyrido[3′,2′:5,6]pyrano[2,3-d]pyrimidine-7,5′-pyrimidine] derivatives.19 This unique reaction provided an elegant synthetic protocol
for the construction of the polycyclic spiro compounds from the combination
of aza-/oxa-Diels–Alder reactions in a one-pot reaction procedure.
In order to further demonstrate the potential synthetic values of
this reaction for the spiro compounds, we initialed the systematic
investigation of various 1-aza-1,4-butadienes and versatile dienophiles
in the domino reactions. Herein, we wish to report the domino reaction
of α,β-unsaturated aldimines and 2-arylidene-1,3-indanediones
for the efficient synthesis of polysubstituted spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridines]. In this domino reaction, 5-arylidene-1,3-indanedione
not only acted as an active dienophile, but also played as a useful
1-oxa-1,4-diene to finish the sequential aza-/oxa-Diels–Alder
reaction.

2 Results and Discussion
At first, according
to our previously established reaction conditions
for the reaction of α,β-unsaturated N-arylaldimines with 2-arylidene-N,N′-dimethylbarbituric acids,19 a
mixture of 2-(p-bromobenzylidene)-1.3-indanedione 1a and N-(4-methoxyphenyl)-3-(p-tolyl)prop-2-en-1-imine 2a was stirred in methylene
dichloride at room temperature overnight, the expected polycyclic
spiro compound 3a was successfully obtained in 31% (Table 1). When the reaction
was carried out in refluxing methylene dichloride for eight or 12
h, the yields of 3a increased to 42 and 45%, respectively.
The reaction in ethanol did not give the expected product. On the
other hand, the reaction in tetrahydrofuran and toluene also resulted
in product 3a in lower yields. When acetonitrile was
employed as the solvent, the reaction afforded product 3a in 20% yield at room temperature. At the elevated temperature (60
°C), 3a was obtained in 68% yield. When a slight
excess of α,β-unsaturated aldimine was used, the yield
of 3a increased to 78% yield. The reaction in refluxing
acetonitrile decreased the yield of 3a to 73%. Finally,
the reaction in a nitrogen atmosphere afforded 3a in
a high yield (82%).

Table 1 Optimizing Reaction
Conditionsa
entry	solvent	ratio	T (°C)	time (h)	yield (%)b	
1	DCM	2:1	rt	6	31	
2	DCM	2:1	reflux	8	42	
3	DCM	2:1	reflux	12	45	
4	EtOH	2:1	rt	8	 	
5	EtOH	2:1	reflux	8	 	
6	toluene	2:1	rt	6	10	
7	toluene	2:1	reflux	12	21	
8	THF	2:1	rt	8	26	
9	THF	2:1	reflux	12	26	
10	MeCN	2:1	rt	12	20	
11	MeCN	2:1	60	6	68	
12	MeCN	2:1.1	60	6	78	
13	MeCN	2:1.1	reflux	10	73	
14	MeCN	2:1.1	60	6	82c	
a Reaction conditions: α,β-unsaturated N-arylaldimine, 2-arylidene-1,3-indanedione, solvent (10.0
mL).

b Isolated yields.

c N2, in Schenk tube.

With the optimized reaction
conditions in hand, the scope of the
reactions was thoroughly investigated. The results are summarized
in Table 2. At first,
2-arylidene-1,3-indanediones with electron-withdrawing fluoro, chloro,
bromo, and nitro groups resulted in the spiropolycycles 3a–3p in 65–86% yields. In these reactions, α,β-unsaturated
aldimines with electron-donating substituents such as methoxy, methyl,
and electron-withdrawing substituents such as chloro, bromo, and nitro
groups can be successfully employed in the reaction and showed less
effect to the yields of products. Second, 2-benzylidene-1,3-indanediones
gave the desired spiropolycycles 3q–3s in moderate
yields. Third, 2-(4-methylbenzylidene)-1,3-indanediones afforded the
products 3t–3v in lower yields. However, 2-arylidene-1,3-indanediones
with m-methyl, m-methoxy, and p-methoxy groups did not result in the expected spiropolycycles.
In these reactions, the retro-Knoevenagel condensation reaction of
α,β-unsaturated aldimines with 2-arylidene-1,3-indanediones
quickly resulted in 2-styrylidene-1,3-indanediones, which can be clearly
determined by thin-layer chromatography (TLC) monitoring and were
isolated in moderate yields. This cross exchange phenomenon was recently
described by Lehn and co-workers as a dynamic covalent metathesis
in the C=C/C=N exchange between Knoevenagel compounds
and imines involving the formation of a four-membered azetidine ring
intermediate.20 The structures of the above-obtained
spiropolycycles 3a–3v were fully characterized
with infrared (IR), high-resolution mass spectra (HRMS), and 1H and 13C NMR spectroscopy. Through several diastereoisomers
might be formed in the reaction, TLC monitoring and 1H
and 13C NMR spectra clearly showed that there is only one
set of characteristic absorptions for the protons in the molecule,
which also indicated only one diastereoisomer existed in the obtained
products.

Table 2 Synthesis of Spiropolycycles 3a–3v via the Aza/Oxa-Diels–Alder Reactiona
entry	compd	Ar1	Ar2	Ar3	yield (%)b	
1	3a	p-BrC6H4	p-CH3C6H4	p-CH3OC6H4	82	
2	3b	p-BrC6H4	p-CH3OC6H4	p-CH3OC6H4	86	
3	3c	p-BrC6H4	p-FC6H4	p-CH3OC6H4	71	
4	3d	p-BrC6H4	p-NO2C6H4	p-CH3OC6H4	65	
5	3e	p-BrC6H4	Ph	Ph	79	
6	3f	p-BrC6H4	Ph	p-CH3OC6H4	86	
7	3g	p-BrC6H4	Ph	p-BrC6H4	82	
8	3h	p-NO2C6H4	Ph	Ph	75	
9	3i	p-NO2C6H4	Ph	p-CH3OC6H4	80	
10	3j	p-NO2C6H4	Ph	p-BrC6H4	71	
11	3k	o-ClC6H4	Ph	p-CH3OC6H4	76	
12	3l	o-BrC6H4	Ph	p-CH3C6H4	85	
13	3m	m-ClC6H4	Ph	Ph	73	
14	3n	m-ClC6H4	Ph	p-CH3OC6H4	69	
15	3o	m-ClC6H4	Ph	p-BrC6H4	78	
16	3p	m-FC6H4	Ph	Ph	68	
17	3q	Ph	Ph	Ph	53	
18	3r	Ph	Ph	p-CH3OC6H4	48	
19	3s	Ph	Ph	p-BrC6H4	67	
20	3t	p-CH3C6H4	Ph	Ph	43	
21	3u	p-CH3C6H4	Ph	p-CH3OC6H4	37	
22	3v	p-CH3C6H4	Ph	p-BrC6H4	32	
a Reaction conditions: α,β-unsaturated N-arylaldimine (1.1 mmol), 2-arylidene-1,3-indanedione (2.0
mmol), CH3CN (10.0 mL), 60 °C, 10 h, N2, in Schenk tube.

b Isolated
yields.

The above three-molecular
reaction usually afforded only one diastereoisomer,
which obviously indicated the reaction proceeding with the one-step
Diels–Alder reaction. For determining the relative configuration
of the obtained products, the single crystal structures of the compounds 3e (Figure 2), 3g, 3i, 3l, and 3p (Figures s1–s4) were successfully
determined by the X-ray diffraction method. It was pleasing to find
that the same relative configuration was observed in the five single
crystals. From Figure 2, it can be seen that the two aryl groups at 2,4-positions exist
on the cis-positions in the newly formed tetrahydropyridyl ring, while
the third aryl group in the newly formed pyran ring also stands on
the cis-position to that of the other two aryl groups. The dihydropyranyl
ring fused to the pyrrolidinyl ring from the endo-direction. Thus,
on the basis of 1H NMR spectra and single crystal structures,
it can be concluded that all spiropolycylces 3a–3v have this kind of 5,6,8-cis/cis-configuration. It should be pointed
out that this kind of configuration is the same as our previously
prepared polycyclic compounds derived from the reaction of α,β-unsaturated N-arylaldimines with 5-arylidene-1,3-dimethylbarbituric
acids. This result clearly showed that this domino aza/oxa-Diels–Alder
reaction of α,β-unsaturated N-arylaldimines
with cyclic dienophiles has the same outcome of stereoselectivity.

Figure 2 Single
crystal structure of the compound 3g.

For developing the scope of this reaction, α,β-unsaturated N-benzylaldimines were also employed in the reaction. The
reaction of various α,β-unsaturated N-benzylaldimines and 2-arylidene-1,3-indanediones in acetonitrile
at room temperature gave the desired spiropolycycles 4a–4r in satisfactory yields. However, the reaction at the elevated temperature
resulted in lower yields of products, which might be due to the relative
instability of α,β-unsaturated N-benzylaldimines
to that of N-arylaldimines. The results are summarized
in Table 3. It can
be seen that benzylamine and its p-CH3O, p-CH3, p-Cl, and p-Br derivatives can be successfully used in the reaction.
Additionally, α,β-unsaturated N-butylaldimine
also reacted smoothly to give the spirocyclic compounds 4q and 4r in good yields. 2-Arylidene-1,3-indanediones
with moderate electron-donating methyl groups and electron-withdrawing
halo groups (F, Cl, and Br) can be successfully employed in the reaction.
2-Arylidene-1,3-indanediones with strong electron-donating groups,
such as the methoxy group, does not take place because these substituents
decrease the electrophilic character of the 2-arylidenedione framework
in the polar Diels–Alder reactions.211H and 13C NMR spectra clearly indicated that
there is only one diastereoisomer existing in the obtained samples.
For example, in the 1H NMR spectrum of compound 4b, the CH2 protons of the benzyl group showed two doublets
at 3.98 ad 3.85 ppm with the germinal coupling constants J = 14.0 Hz. The five CH units in the middle bicyclic ring of pyrano[2,3-b]pyridine gave two doublets at 5.37 and 4.94 ppm, mixed
peaks at 3.74–3.63 ppm, and a singlet at 3.55 ppm. The single
crystal structures of the compounds 4f (Figure 3) and 4m (Figure s5) were determined by X-ray diffraction.
From the figures, it can be seen that they have the same relative
configuration to that of the above-mentioned five compounds, in which
the three aryl groups exist on the cis-positions and the fused pyrano[2,3-b]pyridine] stretched to the endo-direction. Therefore,
the spiropolycycles 3a–3v and 4a–4r have the same relative configuration and were obviously formed via
the same diastereoselective reaction pathway.

Figure 3 Single crystal structure
of the compound 4f.

Table 3 Synthesis of Spiropolycycles 4a–4r via the Aza/Oxa-Diels–Alder Reactiona
entry	compd	Ar1	Ar2	R	yield (%)b	
1	4a	Ph	Ph	Bn	72	
2	4b	Ph	Ph	p-ClC6H4CH2	68	
3	4c	p-ClC6H4	Ph	Bn	72	
4	4d	p-ClC6H4	Ph	p-CH3OC6H4CH2	64	
5	4e	p-ClC6H4	Ph	p-ClC6H4CH2	80	
6	4f	p-ClC6H4	Ph	p-BrC6H4CH2	82	
7	4g	p-ClC6H4	p-ClC6H4	Bn	76	
8	4h	p-ClC6H4	p-CH3OC6H4	Bn	73	
9	4i	m-FC6H4	Ph	p-CH3C6H4CH2	67	
10	4j	m-FC6H4	Ph	p-CH3OC6H4CH2	64	
11	4k	m-FC6H4	Ph	p-ClC6H4CH2	63	
12	4l	m-FC6H4	Ph	p-BrC6H4CH2	73	
13	4m	p-BrC6H4	Ph	Bn	78	
14	4n	p-CH3C6H4	Ph	p-CH3C6H4CH2	60	
15	4o	p-CH3C6H4	Ph	p-ClC6H4CH2	65	
16	4p	m-CH3C6H4	Ph	p-ClC6H4CH2	60	
17	4q	m-FC6H4	Ph	n-C4H9	76	
18	4r	p-BrC6H4	Ph	n-C4H9	62	
a Reaction conditions: α,β-unsaturated N-alkylaldimine (2.0 mmol), 2-arylidene-1,3-indanedione
(1.1 mmol), CH3CN (10.0 mL), rt, 16 h, N2, in
Schenk tube.

b Isolated yields.

For explaining the reaction
mechanism and stereochemistry, a plausible
reaction mechanism was proposed in Scheme 1 on the basis of the previously reported
reactions19,21,22 and the obtained
experiments. First, an aza-Diels–Alder reaction between 1,4-aryl-1-aza-1,3-butadiene
and one molecule of 2-arylidene-1,3-indanedione according to endo-transition
state (A) afford terahydropyridine (B).22 Both the aryl groups exist on the cis-positions
in the intermediate (B). Then, an oxa-Diels–Alder
reaction of the intermediate (B) with another molecule
of 2-arylidene-1,3-indanedione via the endo-transition state (A) gave spiropolycycle 3 or 4, in
which the three aryl group exist on cis-positions. In this domino
reaction, 1,4-aryl-1-aza-1,3-butadiene successfully acted as an active
diene to finish the aza-Diels–Alder reaction, and the initially
formed terahydropyridine successfully played as an electron-rich dienophile
to finish the oxa-Diels–Alder reaction. On the other hand,
5-arylidene-1,3-indanedione not only acted as an active dienophile,
but also played as a useful 1-oxa-1,4-diene to the finish sequential
aza-/oxa-Diels–Alder reaction. Therefore, the reactivity matching
of the two substrates played a key role for this domino aza-/oxa-Diels–Alder
reaction.

Scheme 1 Proposed Concerted Reaction Mechanism
In the investigation process of the above domino aza/oxa-Diels–Alder
reaction, 2,2′-(arylmethylene)bis(1,3-indenediones), which
were the byproduct of the base-catalyzed condensation reaction of
aromatic aldehydes with 1,3-indanedione for the preparation of 2-arylidene-1,3-indanediones,
reacted with α,β-unsaturated N-alkylaldimines
in acetonitrile at room temperature to give 2′,4′-diaryl-6′-(arylamino)dispiro[indene-2,1′-cyclohexane-3′,2″-indene]-1,1″,3,3″-tetraones
(Table 4). All reactions proceeded smoothly
to give dispiro compounds 5a–5n in very high yields.
Because there are three chiral carbon atoms in the dispiro compounds,
a couple of diastereoisomers might be formed in the reaction. 1H NMR spectra clearly indicated that two main diastereoisomers
with broad molecular ratios of 85:15 to 45:55 exist in the products.
By analysis of the stable conformations of 1,3,5-trisubstituted cyclohexane
derivatives, the 1,3,5-cis/cis-diastereoisomer was assigned as the
most stable isomer because the three substituents exist in the equatorial
positions, and the 1,3,5-trans/cis-diastereoisomer was assigned as
a less stable isomer, in which one aryl group and arylamino group
stand in equatorial positions and the other group exists in the axial
position (Scheme 2).
The single crystal structures of the compounds 5g and 5i were successfully determined by X-ray diffraction. It can
be seen that compound 5g belongs to the 1,3,5-cis/cis-configuration
(Figure 4). Compound 5i has a 1,3,5-trans/cis-configuration and the cyclohexyl
ring exists in a twist-boat conformation because the bigger o-bromophenyl group in axial position is unstable (Figure s6).

Figure 4 Single crystal structures of compound 5g.

Scheme 2 Illustration of the Two Main Isomers
of Dispiro Compounds
Table 4 Synthesis
of Dispirocyclohexanes 5a–5n via the Domino Cyclization
Reactiona
entry	compd	Ar1	Ar2	Ar3	yield (%)b	
1	5a	Ph	Ph	Ph	86 (70:30)	
2	5b	p-CH3C6H4	Ph	Ph	89 (45:55)	
3	5c	o-FC6H4	Ph	Ph	92 (70:30)	
4	5d	o-FC6H4	Ph	m-ClC6H4	90 (75:25)	
5	5e	o-ClC6H4	Ph	Ph	88 (40:60)	
6	5f	o-ClC6H4	Ph	m-ClC6H4	91 (33:67)	
7	5g	o-ClC6H4	Ph	p-CH3OC6H4	88 (78:22)	
8	5h	p-BrC6H4	Ph	Ph	87 (65:35)	
9	5i	o-BrC6H4	Ph	Ph	90 (35:65)	
10	5j	o-BrC6H4	Ph	p-CH3C6H4	92 (80:20)	
11	5k	o-BrC6H4	Ph	p-CH3OC6H4	90 (80:20)	
12	5l	o-BrC6H4	p-CH3C6H4	p-CH3OC6H4	93 (75:25)	
13	5m	o-BrC6H4	p-CH3OC6H4	p-CH3OC6H4	88 (85:15)	
14	5n	o-BrC6H4	p-FC6H4	p-CH3OC6H4	85 (85:15)	
a Reaction conditions: α,β-unsaturated N-alkylaldimine (0.5 mmol), 2,2′-(arylmethylene)bis(indene-1,3-dione)
(0.5 mmol), CH3CN (10.0 mL), rt, 4 h, N2, in
Schenk tube.

b Isolated yields.

A plausible reaction mechanism
is also proposed for the formation
of the dispiro compounds (Scheme 3). In polar solvent, 2,2′-(arylmethylene)bis(1,3-indenedione)
equilibrates with its dienol tautomer (D) via the keto–enol
tautomerization. Second, the Michael addition of enol (D) to α,β-unsaturated N-alkylaldimine
resulted in the intermediate (E), which equilibrates
with imine (F) via enamino–imine tautomerization.
Finally, the intramolecular nucleophilic addition of enol to the imine
afforded dispiro compound 5. In the final formation of
the cyclohexane ring, the thermodynamically stable conformations were
obviously formed as the main diastereoisomers. Here, a formal [3 +
3] cycloaddition reaction was successfully finished by the sequential
nucleophilic 1,4-/1,2-additions.

Scheme 3 Plausible Formation Mechanism for
Dispiro Compound 5
3 Conclusions
In summary, we have investigated the domino
reaction of α,β-unsaturated
aldimines with 2-arylidene-1,3-indenediones and 2,2′-(arylmethylene)bis(1,3-indenediones)
and have provided efficient synthetic protocols for polysubstituted
spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridines] and dispiro[indene-2,1′-cyclohexane-3′,2″-indenes].
The reaction has the advantages of using readily available reagents,
catalyst-free, mild conditions, molecular diversity, good yields,
and high diastereoselectivity. The versatile reactivity of α,β-unsaturated
aldimines were sufficiently developed, in which it not only acted
as active dienophile to accomplish the aza-Diels–Alder reaction,
but also acted as dipolarophiles to finish the nucleophilic 1,2-/1,4-addition
reaction. Therefore, this domino reaction might be found potential
applications in organic and medicinal chemistry.

4 Experimental
Section
4.1 General Information
Unless otherwise
noted, all reactants or reagents including dry solvents were obtained
from commercial suppliers and used as received. Analytical TLC was
carried out using 0.25 mm commercial silica gel plates (Merck silica
gel 60 F254). The developed chromatogram was analyzed by a UV lamp
(254 nm). 1H NMR and 13C NMR spectra were obtained
on a Variance 400 M. Chemical shifts (δ) are expressed in parts
per million and are internally referenced. IR spectra were taken on
a PerkinElmer spectrum 100 FTIR and are reported in reciprocal centimeters
(cm–1). HRMS were obtained on an AB 5800 MALDI-TOF/TOF
and are reported as m/z (relative
intensity, TOF). Single crystals were obtained by slowly evaporating
the compounds in the mixture of chloroform and ethanol. X-ray crystallographic
data were collected using a SMART APEX II X-ray diffractometer. Melting
points were measured on a Yanaco micro melting point apparatus and
are uncorrected. The starting materials α,β-unsaturated N-aryl or N-alkylaldimines,23 2-arylidene-1,3-indanediones,24 and 2,2′-(arylmethylene)bis(1,3-indenediones)25 were prepared according to the literature methods.

4.2 General Procedure for the Synthesis of Polycyclic
Compounds 3a–3v
Under a N2 atmosphere, a mixture of α,β-unsaturated N-arylaldimine (1.1 mmol) and 2-arylidene-1,3-indanedione (2.0 mmol)
in dry acetonitrile (10.0 mL) was added in a Schlenk tube. The mixture
was stirred at 60 °C for 6 h. The solvent was removed by rotatory
evaporation at reduced pressure. The residue was subjected to silicon
column chromatography with mixed petroleum ether and ethyl acetate
(v/v = 6:1 to 10:1) as an eluant to give a pure product for analysis.

4.3 (2′S,4′R,4a′S,5′S,11a′S)-2′,5′-Bis(4-bromophenyl)-1′-(4-methoxyphenyl)-4′-(p-tolyl)-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(3a)
The product is obtained as a yellow solid,
82%, 0.719 g, mp 161–163 °C; 1H NMR (400 MHz,
CDCl3): δ 7.51 (d, J = 7.6 Hz, 1H),
7.47–7.31 (m, 9H), 7.11 (t, J = 8.2 Hz, 3H),
7.02 (d, J = 8.4 Hz, 2H), 6.93–6.90 (m, 2H),
6.85 (s, 2H), 6.80–6.76 (m, 3H), 6.68 (d, J = 8.8 Hz, 2H), 5.62 (s, 1H), 5.44 (s, 1H), 3.92 (d, J = 12.4 Hz, 1H), 3.70 (m, 4H, CH), 3.58 (s, 1H), 2.10 (s, 3H); 13C{1H} NMR (100 MHz, CDCl3): δ
201.0, 200.9, 192.4, 175.0, 156.9, 151.5, 145.0, 142.8, 142.1, 141.1,
139.7, 137.5, 137.3, 135.3, 135.0, 134.5, 133.3, 132.3, 131.9, 131.8,
130.9, 130.8, 130.4, 130.2, 129.8, 129.4, 129.4, 128.7, 128.4, 126.1,
123.0, 122.8, 122.7, 122.3, 122.0, 121.3, 121.2, 120.7, 118.4, 113.7,
105.5, 93.8, 62.9, 62.5, 55.1, 45.3, 40.8, 34.9, 20.8; IR (KBr) ν:
3052, 2949, 2833, 1904, 1740, 1701, 1631, 1592, 1504, 1475, 1412,
1364, 1246, 1182, 1070, 1016, 955, 876, 819, 783, 742, 718, 639 cm–1; MS (m/z): HRMS
(ESI-TOF) calcd for C49H36Br2NO5 ([M + H]+), 878.0940; found, 878.0951.

4.4 (2′S,4′R,4a′S,5′S,11a′S)-2′,5′-Bis(4-bromophenyl)-1′,4′-bis(4-methoxyphenyl)-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(3b)
The product is obtained as a yellow solid,
86%, 0.751 g, mp 133–135 °C; 1H NMR (400 MHz,
CDCl3): δ 7.51 (d, J = 7.2 Hz, 1H),
7.48–7.31 (m, 8H), 7.28 (s, 1H), 7.18–7.15 (m, 1H),
7.10 (d, J = 8.8 Hz, 2H), 7.03 (d, J = 8.0 Hz, 2H), 6.91 (d, J = 8.4 Hz, 1H), 6.86–6.84
(m, 3H), 6.77 (d, J = 8.4 Hz, 1H), 6.69–6.66
(m, 3H), 6.54–6.51 (m, 1H), 5.62 (d, J = 2.0
Hz, 1H), 5.44 (s, 1H), 3.90 (d, J = 14.4 Hz, 1H),
3.70 (s, 3H), 3.66 (d, J = 13.2 Hz, 1H), 3.63 (s,
3H), 3.59 (s, 1H); 13C NMR (100 MHz, CDCl3):
δ 200.8, 200.7, 192.3, 174.9, 163.2, 160.8, 157.0, 142.6, 141.8,
141.0, 139.5, 137.2, 135.6, 135.3, 134.3, 133.7, 133.6, 133.3, 132.0,
131.9, 131.4, 131.3, 131.0, 130.9, 130.8, 130.5, 130.3, 129.8, 129.4,
128.3, 127.9, 127.8, 122.4, 122.2, 122.1, 121.4, 121.3, 120.9, 118.5,
115.9, 115.8, 115.7, 115.6, 114.4, 113.7, 105.3, 93.7, 62.8, 62.4,
55.1, 44.9, 40.6, 35.0; IR (KBr) ν: 3070, 2918, 2847, 1891,
1741, 1700, 1627, 1596, 1510, 1476, 1414, 1369, 1250, 1183, 1075,
1024, 953, 822, 743 cm–1; MS (m/z): HRMS (ESI-TOF) calcd for C49H36Br2NO6 ([M + H]+), 894.0889;
found, 894.0893.

4.5 (2′S,4′R,4a′S,5′S,11a′S)-2′,5′-Bis(4-bromophenyl)-4′-(4-fluorophenyl)-1′-(4-methoxyphenyl)-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(3c)
The product is obtained as a yellow solid,
71%, 0.626 g, mp 114–116 °C; 1H NMR (400 MHz,
CDCl3): δ 7.52–7.32 (m, 9H), 7.25–7.23
(m, 1H), 7.10 (d, J = 8.8 Hz, 2H), 7.02 (d, J = 8.4 Hz, 2H), 6.94–6.91 (m, 2H), 6.87–6.82
(m, 3H), 6.78–6.67 (m, 5H), 5.63 (d, J = 1.6
Hz, 1H), 5.44 (s, 1H), 3.92 (d, J = 12.8 Hz, 1H),
3.73–3.70 (m, 4H), 3.55 (s, 1H); 13C NMR (100 MHz,
CDCl3): δ 201.1, 201.0, 192.4, 175.0, 158.9, 156.9,
142.8, 142.1, 141.1, 139.7, 137.3, 135.4, 135.1, 134.5, 133.3, 133.1,
131.9, 131.8, 130.9, 130.9, 130.8, 130.4, 130.3, 129.4, 128.3, 127.3,
127.2, 122.3, 122.0, 121.3, 121.2, 120.8, 118.4, 114.8, 113.7, 113.5,
105.5, 93.8, 62.9, 62.4, 55.1, 55.0, 44.9, 40.9, 34.8; IR (KBr) ν:
3064, 2947, 2837, 1895, 1740, 1701, 1631, 1594, 1504, 1413, 1366,
1240, 1189, 1073, 1008, 954, 876, 825, 743, 636 cm–1; MS (m/z): HRMS (ESI-TOF) calcd
for C48H33Br2FNO5 ([M
+ H]+), 882.0689; found, 882.0693.

4.6 (2′S,4′R,4a′S,5′S,11a′S)-2′,5′-Bis(4-bromophenyl)-1′-(4-methoxyphenyl)-4′-(4-nitrophenyl)-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(3d)
The product is obtained as a yellow solid,
65%, 0.590 g, mp 148–150 °C; 1H NMR (400 MHz,
CDCl3): δ 7.57–7.30 (m, 12H), 7.27 (s, 1H),
7.17 (t, J = 7.8 Hz, 1H), 7.09 (d, J = 8.8 Hz, 2H), 7.03 (d, J = 8.4 Hz, 2H), 6.91–6.88
(m, 1H), 6.84–6.77 (m, 2H), 6.73–6.67 (m, 3H), 5.65
(d, J = 2.0 Hz, 1H), 5.40 (s, 1H), 4.70 (d, J = 12.4 Hz, 1H), 4.07 (d, J = 13.2 Hz,
1H), 2.70 (s, 3H), 3.61 (s, 1H); 13C NMR (100 MHz, CDCl3): δ 200.9, 199.7, 192.6, 174.5, 157.1, 152.0, 142.7,
141.7, 140.5, 139.4, 137.2, 135.7, 135.4, 133.9, 133.3, 132.1, 131.9,
131.9, 130.9, 130.9, 130.6, 130.2, 130.2, 129.4, 128.8, 128.5, 128.4,
125.2, 122.8, 122.0, 121.5, 121.3, 121.0, 118.4, 113.8, 105.7, 93.1,
63.3, 62.7, 55.2, 40.7, 38.8, 35.4; IR (KBr) ν: 3073, 2919,
2850, 1889, 1740, 1699, 1631, 1595, 1522, 1478, 1415, 1359, 1285,
1244, 1193, 1073, 1017, 956, 821, 754, 705 cm–1;
MS (m/z): HRMS (ESI-TOF) calcd for
C48H33Br2N2O7 ([M + H]+), 909.0634; found, 909.0633.

4.7 (2′S,4′R,4a′S,5′S,11a′S)-2′,5′-Bis(4-bromophenyl)-1′,4′-diphenyl-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(3e)
The product is obtained as a yellow solid,
79%, 0.657 g, mp 134–136 °C; 1H NMR (400 MHz,
CDCl3): δ 7.51–7.49 (m, 1H), 7.47–7.31
(m, 9H), 7.26–7.24 (m, 1H), 7.17–7.13 (m, 5H), 7.05–6.99
(m, 5H), 6.94–6.92 (m, 2H), 6.83–6.81 (m, 3H), 5.74
(d, J = 2.4 Hz, 1H), 5.54 (s, 1H), 3.99–3.96
(m, 1H), 3.72 (d, J = 13.2 Hz, 1H), 3.60 (s, 1H); 13C NMR (100 MHz, CDCl3): δ 200.9, 200.7,
192.3, 174.9, 146.9, 142.7, 142.0, 141.0, 137.2, 135.4, 135.3, 135.1,
134.4, 133.3, 132.1, 132.0, 131.8, 131.0, 130.9, 130.7, 130.5, 130.3,
129.4, 128.9, 128.6, 128.0, 127.1, 126.2, 125.3, 122.3, 122.1, 121.3,
121.2, 120.8, 118.5, 105.5, 93.6, 62.8, 61.9, 45.8, 40.5, 35.0; IR
(KBr) ν: 3034, 1742, 1701, 1632, 1593, 1487, 1415, 1370, 1249,
1193, 1073, 1009, 955, 878, 821, 761, 707, 658 cm–1; MS (m/z): HRMS (ESI-TOF) calcd
for C47H32Br2NO4 ([M +
H]+), 832.0698; found, 832.0683.

4.8 (2′S,4′R,4a′S,5′S,11a′S)-2′,5′-Bis(4-bromophenyl)-1′-(4-methoxyphenyl)-4′-phenyl-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(3f)
The product is obtained as a yellow solid,
86%, 0.741 g, mp 134–136 °C; 1H NMR (400 MHz,
CDCl3): δ 7.50 (d, J = 7.2 Hz, 1H),
7.47–7.40 (m, 6H), 7.38–7.33 (m, 2H), 7.30 (d, J = 10.8 Hz, 1H), 7.26–7.25 (m, 1H), 7.15–7.10
(m, 3H), 7.04–6.99 (m, 4H), 6.92 (d, J = 8.0
Hz, 2H), 6.86 (s, 2H), 6.78 (d, J = 8.4 Hz, 1H),
6.68 (d, J = 8.8 Hz, 2H), 5.64 (d, J = 2.0 Hz, 1H), 5.46 (s, 1H), 3.95 (d, J = 12.8
Hz, 1H), 3.73–3.70 (m, 4H), 3.59 (s, 1H); 13C NMR
(100 MHz, CDCl3): δ 1200.9, 200.8, 192.3, 175.0,
157.0, 142.7, 142.0, 141.0, 139.7, 137.3, 135.4, 135.4, 135.0, 134.4,
133.3, 132.0, 131.9, 131.8, 131.0, 130.9, 130.9, 130.4, 130.3, 129.4,
128.9, 128.6, 128.3, 128.0, 126.2, 122.3, 122.0, 121.3, 121.2, 120.8,
118.4, 113.7, 105.5, 93.8, 62.8, 62.3, 55.1, 45.8, 40.6, 35.0; IR
(KBr) ν: 3034, 2955, 2834, 1741, 1700, 1631, 1593, 1506, 1480,
1416, 1372, 1246, 1191, 1074, 1010, 954, 878, 821, 767, 702, 654 cm–1; MS (m/z): HRMS
(ESI-TOF) calcd for C48H34Br2NO5 ([M + H]+), 862.0804; found, 862.0803.

4.9 (2′S,4′R,4a′S,5′S,11a′S)-1′,2′,5′-Tris(4-bromophenyl)-4′-phenyl-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(3g)
The product is obtained as a yellow solid,
82%, 748 g, mp 132–134 °C; 1H NMR (400 MHz,
CDCl3): δ 7.51–7.49 (m, 1H), 7.47–7.42
(m, 5H), 7.41–7.32 (m, 3H), 7.29 (d, J = 8.4
Hz, 2H), 7.25–7.22 (m, 2H), 7.15–7.11 (m, 1H), 7.04–6.99
(m, 6H), 6.97–6.86 (m, 3H), 6.81 (d, J = 8.4
Hz, 2H), 5.66 (d, J = 2.4 Hz, 1H), 5.46 (s, 1H),
3.96–3.93 (m, 1H), 3.69 (d, J = 12.8 Hz, 1H),
3.60 (s, 1H); 13C NMR (100 MHz, CDCl3): δ
200.7, 200.6, 192.2, 174.6, 146.1, 142.6, 141.9, 141.0, 137.1, 135.5,
135.2, 135.1, 134.0, 133.1, 132.0, 131.9, 131.8, 131.3, 130.9, 130.7,
130.6, 130.4, 129.4, 128.9, 128.6, 128.6, 128.1, 126.2, 122.4, 122.1,
121.6, 121.3, 120.9, 118.7, 118.4, 105.6, 93.2, 62.6, 61.8, 45.7,
40.5, 34.9; IR (KBr) ν: 3033, 1896, 1741, 1700, 1633, 1592,
1485, 1413, 1371, 1245, 1191, 1073, 1008, 955, 878, 822, 764, 709,
645 cm–1; MS (m/z): HRMS (ESI-TOF) calcd for C47H31Br3NO4 ([M + H]+), 911.9783; found, 911.9810.

4.10 (2′S,4′R,4a′S,5′S,11a′S)-2′,5′-Bis(4-nitrophenyl)-1′,4′-diphenyl-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(3h)
The product is obtained as a yellow solid,
75%, 574 g, mp 147–149 °C; 1H NMR (400 MHz,
CDCl3): δ 8.21 (d, J = 8.8 Hz, 2H),
7.70–7.68 (m, 1H), 7.60–7.57 (m, 1H), 7.52–7.34
(m, 10H), 7.27 (d, J = 8.8 Hz, 1H), 7.19–7.14
(m, 7H), 7.05–7.02 (m, 3H), 6.97–6.94 (m, 1H), 5.73–5.72
(m, 2H), 4.03 (d, J = 12.8 Hz, 1H), 3.79 (d, J = 12.8 Hz, 1H), 3.75 (s, 1H); 13C NMR (100
MHz, CDCl3): δ 200.3, 200.3, 192.1, 175.0, 150.3,
147.1, 146.8, 146.4, 142.8, 142.4, 140.8, 136.9, 135.8, 135.5, 134.7,
133.0, 132.2, 132.1, 130.6, 130.2, 130.1, 129.1, 128.9, 128.8, 128.6,
128.4, 126.9, 126.0, 125.8, 124.1, 122.8, 122.7, 122.5, 122.2, 121.5,
118.7, 104.8, 93.2, 62.5, 62.0, 45.8, 40.5, 35.5; IR (KBr) ν:
3070, 2948, 2854, 1946, 1740, 1700, 1635, 1595, 1521, 1418, 1345,
1285, 1245, 1195, 1115, 1073, 1007, 957, 855, 759, 703 cm–1; MS (m/z): HRMS (ESI-TOF) calcd
for C47H32N3O8 ([M + H]+), 766.2189; found, 766.2196.

4.11 (2′S,4′R,4a′S,5′S,11a′S)-1′-(4-Methoxyphenyl)-2′,5′-bis(4-nitrophenyl)-4′-phenyl-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(3i)
The product is obtained as a yellow solid,
80%, 0.637 g, mp 149–151 °C; 1H NMR (400 MHz,
CDCl3): δ 8.20 (d, J = 8.4 Hz, 2H),
7.70–7.67 (m, 1H), 7.62–7.59 (m, 1H), 7.52–7.31
(m, 11H), 7.22–7.11 (m, 5H), 7.06–7.02 (m, 2H), 6.95
(s, 1H), 6.68 (d, J = 8.8 Hz, 2H), 5.64–5.63
(m, 2H), 4.01 (d, J = 12.4 Hz, 1H), 3.78 (d, J = 12.8 Hz, 1H), 3.74 (s, 1H), 3.66 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 200.4, 200.3, 192.1, 175.1,
157.3, 150.3, 147.1, 146.7, 142.8, 142.4, 140.8, 139.1, 137.0, 135.8,
135.5, 134.8, 133.1, 132.2, 132.1, 130.6, 130.3, 130.2, 129.1, 128.8,
128.6, 128.4, 128.2, 126.0, 124.1, 122.8, 122.7, 122.5, 122.2, 121.5,
118.7, 114.0, 104.8, 93.4, 62.6, 62.4, 55.2, 45.9, 40.5, 35.5; IR
(KBr) ν: 3071, 2944, 2835, 1741, 1702, 1635, 1596, 1517, 1461,
1420, 1346, 1289, 1243, 1192, 1109, 1073, 1006, 956, 846, 756, 701,
657 cm–1; MS (m/z): HRMS (ESI-TOF) calcd for C48H34N3O9 ([M + H]+), 796.2295; found, 796.2287.

4.12 (2′S,4′R,4a′S,5′S,11a′S)-1′-(4-Bromophenyl)-2′,5′-bis(4-nitrophenyl)-4′-phenyl-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(3j)
The product is obtained as a yellow solid,
71%, 0.599 g, mp 151–153 °C; 1H NMR (400 MHz,
CDCl3): δ 8.21 (d, J = 8.4 Hz, 2H),
7.73–7.70 (m, 1H), 7.64–7.62 (m, 1H), 7.52–7.40
(m, 7H), 7.35–7.28 (m, 5H), 7.24 (s, 1H), 7.19–713 (m,
3H), 7.05–7.03 (m, 4H), 6.92 (s, 1H), 5.65 (s, 2H), 4.01 (d, J = 13.2 Hz, 1H), 3.78–3.74 (m, 2H); 13C NMR (100 MHz, CDCl3): δ 200.2, 200.1, 192.0, 174.7,
150.1, 147.1, 146.9, 145.6, 142.4, 142.3, 140.8, 136.8, 135.9, 135.6,
134.5, 132.9, 132.3, 132.1, 130.7, 130.2, 130.0, 129.2, 128.8, 128.6,
128.5, 128.4, 125.9, 124.1, 123.1, 122.9, 122.5, 122.2, 121.6, 119.4,
118.7, 104.9, 92.8, 62.4, 61.8, 45.8, 40.4, 35.4; IR (KBr) ν:
3071, 2955, 1741, 1702, 1635, 1595, 1520, 1483, 1417, 1347, 1286,
1246, 1192, 1072, 1004, 952, 848, 803, 763, 704 cm–1; MS (m/z): HRMS (ESI-TOF) calcd
for C47H31BrN3O8 ([M +
H]+), 844.1295; found, 844.1307.

4.13 (2′R,4′R,4a′R,5′R,11a′S)-2′,5′-Bis(2-chlorophenyl)-1′-(4-methoxyphenyl)-4′-phenyl-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(3k)
The product is obtained as a yellow solid,
76%, 0.588 g, mp 154–156 °C; 1H NMR (400 MHz,
CDCl3): δ 7.65 (d, J = 7.1 Hz, 1H),
7.48–7.35 (m, 9H), 7.19–6.93 (m, 10H), 6.85 (s, 1H),
6.66–6.62 (m, 4H), 6.08 (s, 1H), 5.69 (s, 1H), 4.16 (d, J = 12.8 Hz, 1H), 3.83 (d, J = 12.8 Hz,
2H), 3.67 (s, 3H); 13C NMR (100 MHz, CDCl3):
δ 202.1, 198.3, 191.9, 175.8, 157.0, 143.4, 141.2, 140.0, 139.3,
137.3, 135.1, 134.9, 134.6, 133.9, 133.6, 133.4, 133.0, 132.5, 132.0,
131.4, 130.5, 130.4, 130.0, 129.4, 128.7, 128.3, 128.1, 128.0, 127.9,
127.8, 126.6, 126.1, 122.6, 122.0, 121.3, 118.5, 113.7, 105.5, 94.6,
62.0, 58.6, 55.2, 46.8, 37.7, 33.6; IR (KBr) ν: 3061, 2920,
1897, 1743, 1702, 1632, 1590, 1510, 1461, 1419, 1371, 1241, 1192,
1072, 1010, 951, 871, 823, 755, 619 cm–1; MS (m/z): HRMS (ESI-TOF) calcd for C48H34Cl2NO5 ([M + H]+),
774.1814; found, 774.1846.

4.14 (2′R,4′R,4a′R,5′R,11a′S)-2′,5′-Bis(2-bromophenyl)-4′-phenyl-1′-(p-tolyl)-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(3l)
The product is obtained as a yellow solid,
85%, 0.721 g, mp 159–161 °C; 1H NMR (400 MHz,
CDCl3): δ 7.67 (d, J = 8.0 Hz, 1H),
7.60 (d, J = 8.5 Hz, 1H), 7.48–7.35 (m, 8H),
7.12–6.78 (m, 13H), 6.65 (t, J = 8.1 Hz, 1H),
6.55–6.51 (m, 1H), 6.07 (s, 1H), 5.76 (s, 1H), 4.17 (d, J = 12.5 Hz, 1H), 3.86–3.81 (m, 2H), 2.17 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 202.2, 198.0,
191.8, 175.7, 144.5, 143.4, 141.3, 140.9, 137.3, 135.1, 134.9, 134.6,
134.5, 134.0, 133.4, 133.0, 132.6, 132.0, 131.6, 130.4, 130.3, 129.2,
128.9, 128.7, 128.4, 127.9, 127.8, 127.2, 127.0, 126.7, 124.6, 124.3,
122.6, 122.1, 121.3, 118.4, 110.0, 105.7, 94.6, 61.9, 61.2, 46.9,
37.7, 35.9, 20.9; IR (KBr) ν: 3035, 2913, 2836, 2332, 1876,
1700, 1630, 1593, 1507, 1459, 1418, 1367, 1241, 1185, 1030, 958, 874,
830, 763, 702, 636 cm–1; MS (m/z): HRMS (ESI-TOF) calcd for C48H34Br2NO4 ([M + H]+), 848.0834; found,
848.0863.

4.15 (2′S,4′R,4a′S,5′S,11a′S)-2′,5′-Bis(3-chlorophenyl)-1′,4′-diphenyl-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(3m)
The product is obtained as a yellow solid,
73%, 0.543 g, mp 163–165 °C; 1H NMR (400 MHz,
CDCl3): δ 7.58–7.32 (m, 9H), 7.18 (t, J = 4.2 Hz, 5H), 7.12 (s, 1H), 7.05–7.01 (m, 4H),
6.96–6.93 (m, 2H), 6.83 (dd, J = 13.3, 7.0
Hz, 2H), 6.74–6.58 (m, 3H), 5.76–5.74 (m, 1H), 5.54,
5.51 (s, 1H), 4.08–4.01 (m, 1H), 3.76–3.72 (m, 1H),
3.63 (s, 1H); 13C NMR (100 MHz, CDCl3): δ
200.8, 200.7, 200.6, 192.4, 175.0, 147.0, 146.7, 145.0, 145.0, 142.8,
142.7, 141.1, 141.0, 137.5, 137.4, 137.3, 135.5, 135.4, 135.4, 135.3,
135.1, 135.0, 134.7, 133.9, 133.3, 133.1, 132.2, 132.2, 132.1, 132.0,
130.4, 130.1, 129.2, 129.1, 128.9, 128.8, 128.7, 128.5, 128.1, 127.9,
127.8, 127.8, 127.6, 127.5, 127.4, 127.3, 127.3, 127.2, 127.1, 126.4,
126.0, 125.9, 125.5, 125.3, 122.4, 122.3, 122.1, 122.0, 121.3, 118.6,
105.3, 93.6, 93.5, 62.8, 62.8, 62.3, 62.2, 45.6, 40.6, 40.5, 35.3,
35.2; IR (KBr) ν: 3062, 2923, 2853, 1954, 1740, 1700, 1632,
1591, 1484, 1465, 1420, 1367, 1246, 1196, 1078, 1004, 954, 877, 757,
700 cm–1; MS (m/z): HRMS (ESI-TOF) calcd for C47H32Cl2NO4 ([M + H]+), 744.1708; found, 744.1709.

4.16 (2′S,4′R,4a′S,5′S,11a′S)-2′,5′-Bis(3-chlorophenyl)-1′-(4-methoxyphenyl)-4′-phenyl-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(3n)
The product is obtained as a yellow solid,
69%, 0.534 g, mp 168–170 °C; 1H NMR (400 MHz,
CDCl3): δ 7.57 (d, J = 7.8 Hz, 1H),
7.47–7.28 (m, 9H), 7.14 (dd, J = 16.6, 8.4
Hz, 4H), 7.05–6.89 (m, 6H), 6.78 (d, J = 7.8
Hz, 1H), 6.79–6.66 (m, 5H), 5.65 (s, 1H), 5.47, 5.43 (s, 1H),
4.06–3.98 (m, 1H), 3.74 (s, 1H), 3.70 (d, J = 2.9 Hz, 3H), 3.62 (s, 1H); 13C NMR (100 MHz, CDCl3): δ 200.8, 200.8, 200.7, 200.7, 192.4, 175.1, 157.1,
157.0, 145.1, 145.0, 142.8, 142.7, 141.1, 141.0, 139.7, 139.5, 137.5,
137.4, 137.3, 135.5, 135.5, 135.3, 135.1, 135.0, 134.6, 133.9, 133.3,
133.0, 132.2, 132.1, 132.0, 130.4, 130.1, 129.4, 129.3, 129.1, 128.9,
128.8, 128.7, 128.7, 128.5, 128.4, 128.0, 127.9, 127.8, 127.8, 127.5,
127.2, 127.2, 126.4, 126.0, 126.0, 122.4, 122.3, 122.0, 121.3, 118.6,
113.8, 113.8, 105.3, 93.8, 93.7, 62.9, 62.9, 62.7, 62.7, 55.2, 45.6,
40.6, 40.6, 35.3, 35.2; IR (KBr) ν: 3064, 2950, 2838, 1740,
1701, 1630, 1591, 1507, 1466, 1421, 1365, 1244, 1079, 1026, 953, 877,
833, 776, 748, 701 cm–1; MS (m/z): HRMS (ESI-TOF) calcd for C48H34Cl2NO5 ([M + H]+), 774.1814; found,
774.1790.

4.17 (2′S,4′R,4a′S,5′S,11a′S)-1′-(4-Bromophenyl)-2′,5′-bis(3-chlorophenyl)-4′-phenyl-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(3o)
The product is obtained as a yellow solid,
78%, 0.688 g, mp 130–132 °C; 1H NMR (400 MHz,
CDCl3): δ 1H NMR (400 MHz, CDCl3): δ 7.56 (d, J = 7.6 Hz, 1H), 7.49–7.35
(m, 7H), 7.32–7.28 (m, 3H), 7.24 (d, J = 6.3
Hz, 2H), 7.18–7.14 (m, 1H), 7.11–7.01 (m, 6H), 6.93
(s, 2H), 6.83–6.79 (m, 1H), 6.76–6.67 (m, 2H), 5.68–5.66
(m, 2.0 Hz, 1H), 5.47, 5.44 (s, 1H), 4.05–3.98 (m, 1H), 3.71
(d, J = 13.0 Hz, 1H), 3.62 (s, 1H); 13C NMR (100 MHz, CDCl3): δ 200.6, 200.6, 200.5, 192.3,
174.7, 146.1, 146.0, 144.9, 144.9, 142.8, 142.6, 141.1, 141.0, 137.1,
137.1, 137.1, 137.0, 135.6, 135.4, 135.2, 135.2, 135.2, 135.1, 134.7,
134.7, 134.2, 133.3, 133.2, 132.2, 132.1, 132.1, 131.9, 131.8, 130.5,
130.1, 130.1, 129.3, 129.2, 129.1, 129.0, 129.0, 128.9, 128.8, 128.8,
128.7, 128.7, 128.2, 128.1, 128.1, 127.8, 127.8, 127.5, 127.4, 127.3,
127.2, 126.3, 126.3, 125.9, 125.9, 122.4, 122.4, 122.1, 121.4, 119.0,
118.8, 118.5, 105.4, 105.4, 93.2, 93.2, 62.7, 62.7, 62.1, 62.1, 45.6,
40.5, 40.5, 35.2, 35.2, 30.3, 29.7; IR (KBr) ν: 3065, 2924,
2853, 1740, 1702, 1631, 1590, 1481, 1420, 1364, 1245, 1195, 1075,
1003, 951, 877, 830, 767, 701 cm–1; MS (m/z): HRMS (ESI-TOF) calcd for C47H31BrCl2NO4 ([M + H]+), 822.0814; found, 822.0822.

4.18 (2′S,4′R,4a′S,5′S,11a′S)-2′,5′-Bis(3-fluorophenyl)-1′,4′-diphenyl-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(3p)
The product is obtained as a yellow solid,
68%, 0.484 g, mp 171–173 °C; 1H NMR (400 MHz,
CDCl3): δ 1H NMR (400 MHz, CDCl3): δ 7.56–7.29 (m, 10H), 7.17 (s, 5H), 7.01–6.95
(m, 6H), 6.87 (d, J = 9.2 Hz, 1H), 6.78–6.66
(m, 3H), 6.40–6.39 (m, 1H), 5.77 (s, 1H), 5.59, 5.53 (s, 1H),
4.05 (d, J = 11.5 Hz, 1H), 3.74 (d, J = 12.5 Hz, 1H), 3.65 (s, 1H); 13C NMR (100 MHz, CDCl3): δ 200.9, 200.9, 200.7, 200.7, 192.5, 175.0, 174.9,
164.3, 161.8, 147.1, 146.9, 145.6, 145.5, 142.8, 141.1, 138.1, 137.8,
137.3, 137.3, 135.4, 135.3, 135.1, 135.0, 133.3, 132.2, 132.1, 132.0,
132.0, 130.4, 130.3, 130.3, 129.4, 129.4, 129.1, 129.0, 128.9, 128.9,
128.7, 128.7, 128.7, 128.6, 128.0, 127.1, 126.4, 126.4, 125.4, 125.3,
125.1, 125.1, 124.9, 123.4, 123.3, 122.4, 122.3, 122.1, 122.0, 121.3,
118.6, 118.6, 116.6, 116.4, 116.2, 116.0, 114.9, 114.8, 114.7, 114.3,
114.1, 113.9, 113.8, 105.5, 105.5, 93.7, 62.8, 62.4, 62.1, 45.7, 45.7,
40.5, 35.3; IR (KBr) ν: 3062, 2907, 1954, 1742, 1701, 1634,
1590, 1475, 1417, 1369, 1245, 1184, 1075, 1007, 959, 874, 765, 701
cm–1; MS (m/z):
HRMS (ESI-TOF) calcd for C47H32F2NO7 ([M + H]+), 712.2299; found, 712.2315.

4.19 (2′S,4′R,4a′S,5′S,11a′S)-1′,2′,4′,5′-Tetraphenyl-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(3q)
The product is obtained as a yellow solid,
53%, 0.358 g, mp 164–166 °C; 1H NMR (400 MHz,
CDCl3): δ 7.47 (d, J = 7.2 Hz, 1H),
7.41–7.30 (m, 10H), 7.26–7.23 (m, 1H), 7.18–7.10
(m, 7H), 7.00–6.92 (m, 6H), 6.81–6.76 (m, 1H), 6.68–6.64
(m, 2H), 5.83 (d, J = 2.4 Hz, 1H), 5.57 (s, 1H),
4.09 (d, J = 13.2 Hz, 1H), 3.77 (d, J = 13.2 Hz, 1H), 3.67 (s, 1H); 13C NMR (100 MHz, CDCl3): δ 201.2, 200.9, 192.6, 174.9, 147.3, 142.9, 142.9,
141.2, 137.5, 135.8, 135.3, 135.0, 134.6, 133.5, 132.1, 131.8, 130.1,
129.4, 129.0, 128.7, 128.5, 128.3, 127.8, 127.7, 127.3, 127.2, 126.8,
126.5, 124.9, 122.2, 121.9, 121.1, 118.4, 106.0, 93.9, 63.1, 62.7,
45.8, 40.6, 35.4; IR (KBr) ν: 3030, 2856, 1955, 1741, 1701,
1632, 1590, 1490, 1457, 1414, 1368, 1286, 1240, 1195, 1146, 1072,
1004, 949, 872, 761, 699, 623 cm–1; MS (m/z): HRMS (ESI-TOF) calcd for C47H34NO4 ([M + H]+), 676.2488; found,
676.2475.

4.20 (2′S,4′R,4a′S,5′S,11a′S)-1′-(4-Methoxyphenyl)-2′,4′,5′-triphenyl-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(3r)
The product is obtained as a yellow solid,
48%, 0.339 g, mp 153–155 °C; 1H NMR (400 MHz,
CDCl3): δ 7.47 (d, J = 6.8 Hz, 1H),
7.43–7.29 (m, 10H), 7.26–7.22 (m, 1H), 7.17–7.12
(m, 5H), 7.00–6.94 (m, 4H), 6.90 (d, J = 7.6
Hz, 1H), 6.79–6.75 (m, 1H), 6.71–6.64 (m, 4H), 5.73
(d, J = 2.4 Hz, 1H), 5.50 (s, 1H), 4.06 (d, J = 13.2 Hz, 1H), 3.76 (d, J = 13.2 Hz,
1H), 3.67 (s, 3H), 3.66 (s, 1H); 13C NMR (100 MHz, CDCl3): δ 201.2, 200.9, 192.6, 175.0, 156.7, 143.0, 142.9,
141.2, 140.2, 137.5, 135.8, 135.2, 134.9, 134.6, 133.5, 132.1, 131.8,
130.1, 129.5, 129.2, 128.7, 128.7, 128.5, 128.4, 127.7, 127.7, 127.3,
126.7, 126.5, 122.2, 121.9, 121.1, 118.3, 113.5, 106.0, 94.1, 63.1,
63.1, 55.1, 45.8, 40.6, 35.4; IR (KBr) ν: 3030, 2917, 2837,
1882, 1739, 1700, 1625, 1591, 1504, 1455, 1411, 1367, 1244, 1188,
1073, 1028, 955, 922, 878, 832, 766, 699, 625 cm–1; MS (m/z): HRMS (ESI-TOF) calcd
for C48H36NO5 ([M + H]+), 706.2593; found, 706.2583.

4.21 (2′S,4′R,4a′S,5′S,11a′S)-1′-(4-Bromophenyl)-2′,4′,5′-triphenyl-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(3s)
The product is obtained as a yellow solid,
67%, 0.505 g, mp 116–118 °C; 1H NMR (400 MHz,
CDCl3): δ 7.47 (d, J = 7.2 Hz, 1H),
7.43–7.37 (m, 5H), 7.34–7.31 (m, 5H), 7.24–7.22
(m, 2H), 7.17–7.12 (m, 3H), 7.04 (d, J = 8.8
Hz, 2H), 7.00 (t, J = 6.4 Hz, 2H), 6.95–6.88
(m, 4H), 6.82–6.78 (m, 1H), 6.72–6.70 (m, 2H), 5.76
(d, J = 2.0 Hz, 1H), 5.50 (s, 1H), 4.06 (d, J = 12.8 Hz, 1H), 3.75 (d, J = 12.8 Hz,
1H), 3.66 (s, 1H); 13C NMR (151 MHz, CDCl3):
δ 201.0, 200.8, 192.5, 174.5, 147.0, 142.9, 141.2, 137.4, 135.6,
135.4, 135.2, 135.1, 134.9, 134.7, 134.1, 133.4, 133.2, 132.1, 131.9,
131.5, 130.2, 129.5, 128.9, 128.8, 128.8, 128.7, 128.6, 128.0, 127.9,
127.7, 127.6, 127.5, 126.9, 126.5, 123.3, 123.3, 122.2, 121.9, 121.2,
118.3, 118.3, 106.1, 93.5, 63.0, 62.5, 45.7, 40.5, 35.4, 29.7; IR
(KBr) ν: 3062, 2921, 2852, 1740, 1701, 1630, 1591, 1487, 1458,
1412, 1365, 1245, 1193, 1073, 1002, 952, 877, 824, 763, 704, 629 cm–1; MS (m/z): HRMS
(ESI-TOF) calcd for C47H33BrNO4 ([M
+ H]+), 754.1593; found, 754.1573.

4.22 (2′S,4′R,4a′S,5′S,11a′S)-1′,4′-Diphenyl-2′,5′-di-p-tolyl-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(3t)
The product is obtained as a yellow solid,
43%, 0.302 g, mp 172–174 °C; 1H NMR (400 MHz,
CDCl3): δ 7.45 (d, J = 6.8 Hz, 1H),
7.40–7.29 (m, 7H), 7.23 (d, J = 7.2 Hz, 1H),
7.17–7.09 (m, 7H), 7.04 (d, J = 8.0 Hz, 2H),
6.98–6.91 (m, 4H), 6.78 (t, J = 6.6 Hz, 2H),
6.55 (d, J = 7.2 Hz, 1H), 6.46 (d, J = 7.6 Hz, 1H), 5.82 (d, J = 2.0 Hz, 1H), 5.51 (s,
1H), 4.04 (d, J = 12.8 Hz, 1H), 3.73 (d, J = 13.2 Hz, 1H), 3.61 (s, 1H), 2.33 (s, 3H), 1.86 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 201.3, 201.0,
192.6, 174.7, 147.5, 142.9, 141.2, 140.0, 137.6, 136.8, 136.2, 135.9,
134.8, 134.5, 134.4, 133.5, 132.2, 132.1, 131.7, 130.0, 129.6, 129.4,
129.3, 128.8, 128.6, 128.5, 128.5, 128.2, 127.8, 127.7, 127.6, 127.2,
126.5, 124.7, 122.9, 122.1, 121.9, 121.0, 118.3, 106.3, 94.0, 63.2,
62.3, 45.8, 40.5, 35.1, 21.0, 20.7; IR (KBr) ν: 3031, 2856,
1740, 1701, 1632, 1591, 1499, 1459, 1416, 1368, 1247, 1195, 1073,
1007, 954, 876, 808, 757, 704, 603 cm–1; MS (m/z): HRMS (ESI-TOF) calcd for C49H38NO4 ([M + H]+), 704.2801; found,
704.2818.

4.23 (2′S,4′R,4a′S,5′S,11a′S)-1′-(4-Methoxyphenyl)-4′-phenyl-2′,5′-di-p-tolyl-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(3u)
The product is obtained as a yellow solid,
37%, 271 g, mp 128–130 °C; 1H NMR (400 MHz,
CDCl3): δ 7.47 (d, J = 7.2 Hz, 1H),
7.42–7.27 (m, 8H), 7.14–7.09 (m, 5H), 7.05–7.03
(m, 2H), 6.99–6.97 (m, 2H), 6.95–6.92 (m, 1H), 6.82–6.76
(m, 2H), 6.66 (d, J = 9.2 Hz, 1H), 6.55 (d, J = 7.2 Hz, 1H), 6.48 (d, J = 8.0 Hz, 1H),
5.72 (d, J = 2.4 Hz, 1H), 5.45 (s, 1H), 4.02 (d, J = 12.0 Hz, 1H), 3.73 (d, J = 12.4 Hz,
1H), 3.68 (s, 3H), 3.61 (s, 1H), 2.33 (s, 3H), 1.88 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 201.3, 201.0,
192.6, 174.8, 156.6, 143.0, 141.2, 140.3, 140.0, 137.6, 136.7, 136.2,
135.9, 134.8, 134.5, 133.5, 132.2, 132.1, 131.7, 130.0, 129.4, 129.3,
129.0, 128.6, 128.5, 128.4, 127.8, 127.6, 127.6, 126.5, 122.1, 121.9,
121.0, 118.3, 113.4, 106.2, 94.2, 63.2, 62.7, 55.1, 45.8, 40.6, 35.1,
21.0, 20.7; IR (KBr) ν: 3033, 2921, 2850, 1741, 1701, 1631,
1593, 1509, 1461, 1419, 1370, 1245, 1192, 1075, 1031, 955, 878, 817,
765, 709, 649, 606 cm–1; MS (m/z): HRMS (ESI-TOF) calcd for C50H40NO5 ([M + H]+), 734.2906; found, 734.2922.

4.24 (2′S,4′R,4a′S,5′S,11a′S)-1′-(4-Bromophenyl)-4′-phenyl-2′,5′-di-p-tolyl-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(3v)
The product is obtained as a yellow solid,
32%, 0.250 g, mp 149–151 °C; 1H NMR (400 MHz,
CDCl3): δ 7.47 (d, J = 7.2 Hz, 1H),
7.41–7.34 (m, 6H), 7.33–7.28 (m, 3H), 7.24–7.21
(m, 2H), 7.12 (d, J = 7.6 Hz, 2H), 7.04 (d, J = 8.4 Hz, 4H), 7.00–6.98 (m, 2H), 6.93–6.91
(m, 1H), 6.80–6.75 (m, 2H), 6.58 (d, J = 8.0
Hz, 1H), 6.50 (d, J = 8.0 Hz, 1H), 5.74 (d, J = 2.0 Hz, 1H), 5.45 (s, 1H), 4.01 (d, J = 12.4 Hz, 1H), 3.71 (d, J = 12.4 Hz, 1H), 3.61
(s, 1H), 2.34 (s, 3H), 1.90 (s, 3H); 13C NMR (100 MHz,
CDCl3): δ 201.1, 200.9, 192.5, 174.4, 146.7, 142.9,
141.2, 139.9, 137.4, 137.1, 136.3, 135.6, 134.9, 134.6, 133.4, 132.1,
131.8, 131.4, 130.1, 129.4, 129.3, 128.8, 128.7, 128.7, 128.5, 128.0,
127.7, 127.5, 126.5, 122.2, 121.9, 121.1, 118.2, 118.1, 109.9, 106.3,
93.6, 63.0, 62.2, 45.7, 40.5, 35.0, 29.6, 21.0, 20.7; IR (KBr) ν:
3029, 2920, 2858, 1741, 1700, 1634, 1592, 1485, 1415, 1368, 1246,
1191, 1072, 1008, 957, 878, 812, 763, 708, cm–1;
MS (m/z): HRMS (ESI-TOF) calcd for
C49H37BrNO4 ([M + H]+),
782.1906; found, 782.1910.

4.25 2-(3-(4-Methoxyphenyl)allylidene)-1H-indene-1,3(2H)-dione
The product
is obtained as a yellow solid, 34%, mp 212–214 °C; 1H NMR (400 MHz, CDCl3): δ 8.37–8.30
(m, 1H), 7.96–7.94 (m, 2H), 7.80–7.76 (m, 2H), 7.65–7.62
(m, 3H), 7.31 (d, J = 15.4 Hz, 1H), 6.95 (d, J = 8.7 Hz, 2H), 3.87 (s, 3H); 13C NMR (100 MHz,
CDCl3): δ 190.74, 190.30, 162.14, 151.45, 145.39,
142.07, 140.76, 134.89, 134.76, 130.68, 128.47, 126.65, 122.94, 122.76,
121.68, 114.57, 55.46; IR (KBr) ν: 3042, 2990, 2845, 2718, 2563,
2031, 1858, 1747, 1679, 1578, 1508, 1461, 1367, 1303, 1257, 1214,
1163, 1022, 986, 864, 818, 733, 698, 601 cm–1; MS
(m/z): HRMS (ESI-TOF) calcd for
C19H15O3 ([M + H]+), 291.1021;
found, 291.1002.

4.26 General Procedure for
the Synthesis of Polycyclic
Compounds 4a–4r
Under a N2 atmosphere, a mixture of α,β-unsaturated N-arylaldimine (1.1 mmol) and 2-arylidene-1,3-indanedione (2.0 mmol)
in dry acetonitrile (10.0 mL) was added in a Schlenk tube. The mixture
was stirred at room temperature for 24 h. The solvent was removed
by rotatory evaporation at reduced pressure. The residue was subjected
to silicon column chromatography with mixed petroleum ether and ethyl
acetate (v/v = 8:1 to 12:1) as an eluant to give a pure product for
analysis.

4.27 (2′S,4′R,4a′S,5′S,11a′S)-1′-Benzyl-2′,4′,5′-triphenyl-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(4a)
The product is obtained as a yellow solid,
72%, 0.497 g, mp 158–160 °C; 1H NMR (400 MHz,
CDCl3): δ 7.50–7.45 (m, 2H), 7.43–7.32
(m, 9H), 7.27 (s, 1H), 7.25–7.19 (m, 3H), 7.14–7.06
(m, 4H), 6.96–6.87 (m, 9H), 5.45 (d, J = 2.0
Hz, 1H), 4.95 (s, 1H), 4.01–3.89 (m, 2H), 3.76–3.64
(m, 2H), 3.54 (s, 1H); 13C NMR (100 MHz, CDCl3): δ 201.3, 192.6, 174.7, 143.0, 142.9, 141.2, 137.8, 137.0,
135.8, 135.7, 135.0, 134.7, 133.6, 132.0, 130.1, 128.7, 128.7, 128.6,
128.6, 128.5, 128.5, 128.4, 128.2, 127.7, 127.3, 127.2, 126.7, 126.6,
122.2, 121.9, 121.1, 118.2, 106.6, 90.1, 64.9, 63.5, 52.7, 45.7, 39.6,
35.4; IR (KBr) ν: 3030, 2920, 2859, 1958, 1883, 1816, 1738,
1701, 1632, 1593, 1492, 1457, 1409, 1385, 1361, 1249, 1194, 1071,
1022, 955, 887, 761, 701, 618 cm–1; MS (m/z): HRMS (ESI-TOF) calcd for C48H36NO4 ([M + H]+), 690.2644; found,
690.2652.

4.28 (2′S,4′R,4a′S,5′S,11a′S)-1′-(4-Chlorobenzyl)-2′,4′,5′-triphenyl-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(4b)
The product is obtained as a yellow solid,
68%, 0.492 g, mp 169–171 °C; 1H NMR (400 MHz,
CDCl3): δ 7.48 (t, J = 8.5 Hz, 2H),
7.42–7.33 (m, 6H), 7.24–7.16 (m, 9H), 7.09 (br s, 1H),
6.96–6.86 (m, 9H), 5.37 (d, J = 2.4 Hz, 1H),
4.94 (d, J = 1.8 Hz, 1H), 3.98 (d, J = 14.0 Hz, 1H), 3.85 (d, J = 14.0 Hz, 1H), 3.74–3.63
(m, 2H), 3.55 (s, 1H); 13C NMR (100 MHz, CDCl3): δ 201.3, 201.1, 192.5, 174.5, 142.9, 142.9, 141.2, 137.7,
135.7, 135.6, 135.5, 135.1, 134.8, 133.5, 132.9, 132.0, 132.0, 130.2,
129.9, 128.7, 128.6, 128.5, 128.5, 128.3, 128.2, 127.8, 127.3, 126.7,
126.6, 122.2, 121.9, 121.2, 118.2, 106.6, 90.0, 64.8, 63.4, 52.2,
45.6, 39.7, 35.4; IR (KBr) ν: 3029, 2944, 2860, 1960, 1822,
1735, 1696, 1629, 1590, 1489, 1458, 1414, 1378, 1276, 1177, 1080,
1016, 945, 895, 821, 764, 703, 659, 621 cm–1; MS
(m/z): HRMS (ESI-TOF) calcd for
C48H35ClNO4 ([M + H]+),
724.2255; found, 724.2266.

4.29 (2′S,4′R,4a′S,5′S,11a′S)-1′-Benzyl-2′,5′-bis(4-chlorophenyl)-4′-phenyl-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(4c)
The product is obtained as a yellow solid,
72%, 0.546 g, mp 132–134 °C; 1H NMR (400 MHz,
CDCl3): δ 7.52–7.41 (m, 6H), 7.38–7.28
(m, 7H), 7.24 (d, J = 6.1 Hz, 1H), 7.16–7.06
(m, 4H), 6.96–6.94 (m, 5H), 6.88–6.84 (m, 3H), 5.36
(s, 1H), 4.93 (s, 1H), 3.97 (d, J = 13.7 Hz, 1H),
3.83 (d, J = 13.7 Hz, 1H), 3.63 (s, 2H), 3.50 (s,
1H); 13C NMR (100 MHz, CDCl3): δ 201.1,
201.0, 192.4, 174.7, 142.8, 141.5, 141.1, 137.5, 136.6, 135.4, 135.3,
135.1, 134.3, 134.0, 133.4, 132.5, 132.1, 131.9, 130.3, 128.8, 128.7,
128.6, 128.6, 128.6, 128.5, 127.9, 127.4, 126.4, 122.4, 122.1, 121.3,
118.4, 106.2, 89.8, 64.1, 63.2, 52.8, 45.7, 39.5, 34.9; IR (KBr) ν:
3032, 2871, 1894, 1700, 1638, 1595, 1488, 1416, 1371, 1250, 1184,
1092, 1017, 948, 893, 822, 766, 707, 612 cm–1; MS
(m/z): HRMS (ESI-TOF) calcd for
C48H34Cl2NO4 ([M + H]+), 758.1865; found, 758.1878.

4.30 (2′S,4′R,4a′S,5′S,11a′S)-2′,5′-Bis(4-chlorophenyl)-1′-(4-methoxybenzyl)-4′-phenyl-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(4d)
The product is obtained as a white solid,
64%, 0.504 g, mp 154–156 °C; 1H NMR (400 MHz,
CDCl3): δ 7.52–7.42 (m, 9H), 7.20 (d, J = 8.0 Hz, 2H), 7.15–7.06 (m, 4H), 7.01–6.95
(m, 5H), 6.89–6.80 (m, 5H), 5.33 (s, 1H), 4.90 (s, 1H), 3.89–3.75
(m, 5H), 3.60 (s, 2H), 3.50 (s, 1H); 13C NMR (100 MHz,
CDCl3): δ 201.1, 201.1, 192.4, 174.8, 159.0, 142.8,
141.6, 141.1, 137.5, 135.4, 135.3, 135.1, 134.4, 133.9, 133.5, 132.4,
132.1, 131.9, 130.3, 130.0, 128.8, 128.7, 128.6, 128.5, 128.3, 127.9,
126.4, 122.3, 122.0, 121.3, 118.4, 113.9, 106.1, 89.7, 64.1, 63.3,
55.3, 52.3, 45.6, 39.6, 34.9; IR (KBr) ν: 3039, 2948, 2839,
1903, 1739, 1699, 1630, 1593, 1499, 1463, 1411, 1251, 1188, 1093,
1021, 950, 888, 823, 763, 708, 657, 609 cm–1; MS
(m/z): HRMS (ESI-TOF) calcd for
C49H36Cl2NO5 ([M + H]+), 788.1971; found, 788.1988.

4.31 (2′S,4′R,4a′S,5′S,11a′S)-1′-(4-Chlorobenzyl)-2′,5′-bis(4-chlorophenyl)-4′-phenyl-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(4e)
The product is obtained as a yellow solid,
80%, 0.634 g, mp 163–165 °C; 1H NMR (400 MHz,
CDCl3): δ 7.53–7.34 (m, 8H), 7.25–7.22
(m, 4H), 7.16 (d, J = 8.2 Hz, 3H), 7.10–7.06
(m, 2H), 6.96 (d, J = 3.8 Hz, 5H), 6.89–6.85
(m, 3H), 5.29 (s, 1H), 4.92 (s, 1H), 3.98 (d, J =
14.4 Hz, 1H), 3.78 (d, J = 14.0 Hz, 1H), 3.65–3.58
(m, 2H), 3.51 (s, 1H); 13C NMR (100 MHz, CDCl3): δ 201.2, 200.9, 192.3, 174.5, 142.8, 141.4, 141.0, 137.4,
135.5, 135.3, 135.3, 135.2, 135.2, 134.1, 134.1, 133.3, 133.2, 132.7,
132.1, 131.9, 130.4, 129.8, 129.1, 128.8, 128.7, 128.7, 128.6, 128.6,
128.0, 126.3, 122.4, 122.0, 121.4, 118.3, 106.2, 89.8, 64.1, 63.1,
52.3, 45.7, 39.7, 34.9; IR (KBr) ν: 3059, 2912, 2852, 1895,
1816, 1698, 1628, 1591, 1486, 1409, 1249, 1187, 1091, 1014, 949, 892,
817, 765, 710 cm–1; MS (m/z): HRMS (ESI-TOF) calcd for C48H33Cl3NO4 ([M + H]+), 792.1475; found,
792.1501.

4.32 (2′S,4′R,4a′S,5′S,11a′S)-1′-(4-Bromobenzyl)-2′,5′-bis(4-chlorophenyl)-4′-phenyl-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(4f)
The product is obtained as a yellow solid,
82%, 0.685 g, mp 169–171 °C; 1H NMR (400 MHz,
CDCl3): δ 7.52–7.35 (m, 10H), 7.18–7.09
(m, 6H), 7.09 (s, 1H), 6.96–6.86 (m, 8H), 5.28 (s, 1H), 4.92
(s, 1H), 3.96 (d, J = 14.2 Hz, 1H), 3.76 (d, J = 13.7 Hz, 1H), 3.65–3.58 (m, 2H), 3.51 (s, 1H); 13C NMR (100 MHz, CDCl3): δ 201.2, 200.9,
192.3, 174.5, 142.8, 141.4, 141.0, 137.4, 135.8, 135.5, 135.2, 134.1,
134.0, 133.3, 132.7, 132.1, 131.9, 131.7, 130.4, 130.2, 128.8, 128.7,
128.6, 128.6, 128.0, 126.3, 122.4, 122.1, 121.4, 121.3, 118.3, 106.2,
89.8, 64.1, 63.1, 52.4, 45.7, 39.7, 34.9; IR (KBr) ν: 3054,
2911, 2849, 1896, 1698, 1591, 1483, 1405, 1250, 1186, 1088, 1012,
951, 891, 819, 763, 712 cm–1; MS (m/z): HRMS (ESI-TOF) calcd for C48H33BrCl2NO4 ([M + H]+), 836.0970;
found, 836.0982.

4.33 (2′S,4′R,4a′S,5′S,11a′S)-1′-Benzyl-2′,4′,5′-tris(4-chlorophenyl)-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(4g)
The product is obtained as a yellow solid,
76%, 0.602 g, mp 164–166 °C; 1H NMR (400 MHz,
CDCl3): δ 7.53–7.36 (m, 8H), 7.28 (s, 5H),
7.12–7.10 (m, 5H), 6.96 (d, J = 8.1 Hz, 4H),
6.84 (t, J = 8.0 Hz, 3H), 5.35 (s, 1H), 4.90 (s,
1H), 3.95 (d, J = 13.6 Hz, 1H), 3.83 (d, J = 13.6 Hz, 1H), 3.61 (s, 2H), 3.42 (s, 1H); 13C NMR (100 MHz, CDCl3): δ 201.0, 200.8, 192.3, 174.6,
142.7, 141.2, 141.0, 137.4, 136.4, 135.7, 135.5, 134.1, 134.1, 133.8,
133.4, 133.2, 132.6, 132.1, 130.4, 129.1, 129.0, 128.8, 128.7, 128.6,
128.6, 127.8, 127.5, 122.5, 122.2, 121.3, 118.4, 106.0, 89.6, 64.3,
63.1, 52.8, 44.8, 39.5, 34.9; IR (KBr) ν: 3064, 2958, 2850,
1910, 1820, 1698, 1593, 1484, 1411, 1360, 1252, 1195, 1092, 1014,
955, 886, 827, 754, 703, 634 cm–1; MS (m/z): HRMS (ESI-TOF) calcd for C48H33Cl3NO4 ([M + H]+), 792.1475;
found, 792.1480.

4.34 (2′S,4′R,4a′S,5′S,11a′S)-1′-Benzyl-2′,5′-bis(4-chlorophenyl)-4′-(4-methoxyphenyl)-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(4h)
The product is obtained as a yellow solid,
73%, 0.575 g, mp 131–133 °C; 1H NMR (400 MHz,
CDCl3): δ 7.54–7.41 (m, 6H), 7.37–7.28
(m, 7H), 7.23 (s, 1H), 7.11–7.05 (m, 3H), 6.95 (s, 3H), 6.87
(d, J = 8.0 Hz, 2H), 6.79 (d, J =
8.0 Hz, 1H), 6.63 (d, J = 9.0 Hz, 1H), 6.48 (d, J = 8.3 Hz, 1H), 5.35 (s, 1H), 4.90 (s, 1H), 3.96 (d, J = 13.5 Hz, 1H), 3.82 (d, J = 13.6 Hz,
1H), 3.59 (m, 5H), 3.50 (s, 1H); 13C NMR (100 MHz, CDCl3): δ 201.4, 201.2, 192.4, 174.7, 158.9, 142.9, 141.5,
141.1, 137.6, 136.6, 135.4, 135.2, 134.4, 133.9, 133.4, 133.0, 132.4,
132.1, 130.3, 128.7, 128.6, 128.6, 128.5, 127.4, 127.3, 122.4, 122.0,
121.2, 118.3, 114.6, 113.5, 106.2, 89.8, 64.2, 63.3, 55.1, 52.8, 44.8,
39.8, 34.7; IR (KBr) ν: 3033, 2943, 2839, 1898, 1699, 1594,
1502, 1407, 1254, 1182, 1093, 1022, 952, 889, 824, 755, 708 cm–1; MS (m/z): HRMS
(ESI-TOF) calcd for C49H36Cl2NO4 ([M + H]+), 788.1971; found, 788.1978.

4.35 (2′S,4′R,4a′S,5′S,11a′S)-2′,5′-Bis(3-fluorophenyl)-1′-(4-methylbenzyl)-4′-phenyl-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(4i)
The product is obtained as a yellow solid,
67%, 0.496 g, mp 155–157 °C; 1H NMR (400 MHz,
CDCl3): δ 7.49–7.34 (m, 8H), 7.18 (t, J = 8.4 Hz, 3H), 7.13–7.07 (m, 5H), 6.96 (s, 3H),
6.83–6.73 (m, 4H), 6.62 (t, J = 10.6 Hz, 2H),
5.35 (s, 1H), 4.93 (s, 1H), 3.87 (q, J = 13.4, 12.7
Hz, 2H), 3.67–3.60 (m, 2H), 3.51 (s, 1H), 2.32 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 201.0, 192.4,
174.8, 164.0, 161.6, 145.6, 142.8, 141.1, 137.5, 137.2, 135.3, 135.0,
133.5, 132.1, 131.9, 130.3, 130.0, 129.9, 129.2, 128.7, 128.5, 127.9,
126.5, 123.0, 122.0, 121.2, 118.4, 114.4, 114.2, 113.7, 113.5, 106.0,
89.6, 63.2, 52.7, 45.5, 39.4, 35.2, 21.0; IR (KBr) ν: 3037,
2960, 2918, 2854, 1894, 1738, 1698, 1592, 1463, 1415, 1247, 1189,
1146, 1074, 1025, 938, 880, 764, 702, 632 cm–1;
MS (m/z): HRMS (ESI-TOF) calcd for
C49H36F2NO4 ([M + H]+), 740.2612; found, 740.2620.

4.36 (2′S,4′R,4a′S,5′S,11a′S)-2′,5′-Bis(3-fluorophenyl)-1′-(4-methoxybenzyl)-4′-phenyl-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(4j)
The product is obtained as a yellow solid,
64%, 0.484 g, mp 129–131 °C; 1H NMR (400 MHz,
CDCl3): δ 7.49–7.38 (m, 8H), 7.24–7.08
(m, 6H), 6.96 (s, 3H), 6.87–6.74 (m, 6H), 6.62 (d, J = 6.0 Hz, 2H), 5.36 (s, 1H), 4.90 (d, J = 14.9 Hz, 1H), 3.90–3.79 (m, 5H), 3.66–3.60 (m, 2H),
3.52 (s, 1H); 13C NMR (100 MHz, CDCl3): δ
201.0, 192.4, 174.8, 164.0, 161.6, 159.0, 145.6, 145.6, 142.8, 141.1,
137.5, 135.3, 135.0, 133.5, 132.1, 131.9, 130.3, 130.1, 130.0, 129.9,
128.7, 128.6, 127.9, 126.5, 123.0, 123.0, 122.3, 122.0, 121.3, 118.4,
114.4, 114.2, 114.0, 113.7, 113.5, 106.0, 89.6, 63.2, 55.3, 52.4,
45.5, 39.4, 35.2; IR (KBr) ν: 3042, 2947, 2844, 1956, 1882,
1701, 1595, 1502, 1455, 1388, 1249, 1168, 1076, 1024, 941, 878, 761,
701, 638 cm–1; MS (m/z): HRMS (ESI-TOF) calcd for C49H36F2NO5 ([M + H]+), 756.2562; found, 756.2566.

4.37 (2′S,4′R,4a′S,5′S,11a′S)-1′-(4-Chlorobenzyl)-2′,5′-bis(3-fluorophenyl)-4′-phenyl-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(4k)
The product is obtained as a yellow solid,
63%, 0.479 g, mp 163–165 °C; 1H NMR (400 MHz,
CDCl3): δ 7.53–7.35 (m, 10H), 7.19–7.10
(m, 4H), 7.97–6.86 (m, 6H), 6.75–7.61 (m, 5H), 5.31
(s, 1H), 4.93 (s, 1H), 3.99 (d, J = 13.7 Hz, 1H),
3.82 (d, J = 13.2 Hz, 1H), 3.69 (d, J = 12.8 Hz, 1H), 3.61 (d, J = 13.2 Hz, 1H), 3.53
(s, 1H); 13C NMR (100 MHz, CDCl3): δ 201.1,
200.8, 192.3, 174.6, 164.1, 161.7, 145.5, 145.4, 142.8, 141.0, 138.1,
138.1, 137.4, 135.4, 135.2, 135.1, 133.4, 133.2, 132.2, 131.9, 130.4,
130.1, 130.0, 129.9, 128.8, 128.7, 128.6, 128.0, 126.4, 122.9, 122.8,
122.4, 122.1, 121.4, 118.4, 114.5, 114.2, 113.9, 113.7, 106.0, 89.7,
63.1, 52.3, 45.5, 39.5, 35.2; IR (KBr) ν: 3058, 2947, 2909,
2863, 1959, 1695, 1590, 1482, 1376, 1268, 1178, 1078, 1012, 933, 879,
752, 700 cm–1; MS (m/z): HRMS (ESI-TOF) calcd for C48H33ClF2NO ([M + H]+), 760.2066; found, 760.2069.

4.38 (2′S,4′R,4a′S,5′S,11a′S)-1′-(4-Bromobenzyl)-2′,5′-bis(3-fluorophenyl)-4′-phenyl-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(4l)
The product is obtained as a yellow solid,
73%, 0.587 g, mp 170–172 °C; 1H NMR (400 MHz,
CDCl3): δ 7.53–7.39 (m, 10H), 7.20–7.11
(m, 5H), 7.97–6.86 (m, 6H), 6.75–6.61 (m, 4H), 5.31
(s, 1H), 4.94 (s, 1H), 3.98 (d, J = 14.1 Hz, 1H),
3.81 (d, J = 14.3 Hz, 1H), 3.71–3.60 (m, 2H),
3.53 (s, 1H); 13C NMR (100 MHz, CDCl3): δ
201.0, 200.8, 192.3, 174.6, 164.1, 161.7, 145.5, 145.4, 142.8, 141.0,
138.1, 138.0, 137.4, 135.4, 135.2, 135.1, 133.4, 132.1, 131.9, 131.7,
130.4, 130.3, 130.1, 130.0, 128.8, 128.6, 128.0, 126.4, 122.8, 122.8,
122.4, 122.0, 121.4, 118.3, 114.5, 114.3, 113.9, 113.7, 106.1, 89.7,
63.1, 52.4, 45.5, 39.5, 35.1; IR (KBr) ν: 3056, 2946, 2908,
2862, 1960, 1736, 1696, 1591, 1482, 1378, 1248, 1180, 1072, 1006,
933, 880, 761, 701, 639 cm–1; MS (m/z): HRMS (ESI-TOF) calcd for C48H33BrF2N5O6 ([M + H]+), 804.1561; found, 804.1556.

4.39 (2′S,4′R,4a′S,5′S,11a′S)-1′-Benzyl-2′,5′-bis(4-bromophenyl)-4′-phenyl-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(4m)
The product is obtained as a yellow solid,
78%, 0.661 g, mp 137–139 °C; 1H NMR (400 MHz,
CDCl3): δ 7.52–7.41 (m, 7H), 7.36 (t, J = 6.6 Hz, 2H), 7.33–7.28 (m, 5H), 7.24 (s, 2H),
7.15–7.05 (m, 5H), 6.96–6.94 (m, 2H), 6.86–6.81
(m, 3H), 5.36 (s, 1H), 4.91 (s, 1H), 3.97 (d, J =
13.7 Hz, 1H), 3.83 (d, J = 13.7 Hz, 1H), 3.62 (s,
2H), 3.48 (s, 1H); 13C NMR (100 MHz, CDCl3):
δ 201.1, 201.0, 192.4, 174.7, 142.8, 142.0, 141.1, 137.5, 136.5,
135.4, 135.3, 135.2, 134.9, 133.4, 132.1, 131.9, 131.6, 130.3, 129.1,
128.8, 128.6, 128.5, 127.9, 127.5, 126.4, 122.4, 122.2, 122.1, 121.3,
120.6, 118.4, 106.1, 89.8, 64.2, 63.2, 52.9, 45.7, 39.5, 35.0; IR
(KBr) ν: 3032, 2868, 1893, 1826, 1700, 1637, 1595, 1483, 1414,
1371, 1249, 1184, 1074, 1012, 948, 892, 818, 765, 703, 654 cm–1; MS (m/z): HRMS
(ESI-TOF) calcd for C48H34Br2NO4 ([M + H]+), 848.0834; found, 848.0844.

4.40 (2′S,4′R,4a′S,5′S,11a′S)-1′-(4-Methylbenzyl)-4′-phenyl-2′,5′-di-p-tolyl-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(4n)
The product is obtained as a yellow solid,
60%, 0.439 g, mp 150–152 °C; 1H NMR (400 MHz,
CDCl3): δ 7.49–7.44 (m, 2H), 7.40–7.31
(m, 6H), 7.19 (t, J = 6.9 Hz, 3H), 7.11–7.00
(m, 4H), 6.92 (d, J = 5.6 Hz, 4H), 6.86–6.81
(m, 4H), 6.77 (s, 2H), 5.41 (s, 1H), 4.89 (s, 1H), 3.91–3.82
(m, 2H), 3.68–3.59 (m, 2H), 3.49 (s, 1H), 2.32 (s, 3H), 2.26
(s, 3H), 2.03 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 201.5, 201.3, 192.7, 174.6, 143.0, 141.2, 140.0, 137.9,
137.7, 136.6, 135.9, 135.8, 134.9, 134.6, 134.5, 134.0, 133.7, 132.7,
131.9, 131.9, 130.0, 129.1, 129.0, 128.8, 128.5, 128.4, 127.8, 127.6,
127.2, 126.7, 122.2, 121.9, 121.0, 118.2, 106.9, 90.2, 64.5, 63.6,
52.4, 45.7, 39.4, 35.1, 21.1, 21.0, 20.9; IR (KBr) ν: 3029,
2918, 2862, 1956, 1699, 1646, 1591, 1487, 1372, 1245, 1172, 1092,
1013, 952, 893, 815, 758, 706, 612 cm–1; MS (m/z): HRMS (ESI-TOF) calcd for C51H42NO4 ([M + H]+), 732.3114; found,
732.3142.

4.41 (2′S,4′R,4a′S,5′S,11a′S)-1′-(4-Chlorobenzyl)-4′-phenyl-2′,5′-di-p-tolyl-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(4o)
The product is obtained as a yellow solid,
65%, 0.489 g, mp 145–147 °C; 1H NMR (400 MHz,
CDCl3): δ 7.50–7.31 (m, 8H), 7.26–7.14
(m, 6H), 7.08–7.05 (m, 1H), 6.98–6.93 (m, 4H), 6.84
(d, J = 7.8 Hz, 4H), 6.76 (d, J =
7.7 Hz, 2H), 5.35 (s, 1H), 4.90 (s, 1H), 3.95 (d, J = 14.4 Hz, 1H), 3.84 (d, J = 13.7 Hz, 1H), 3.64
(q, J = 13.2 Hz, 2H), 3.51 (s, 1H), 2.29 (s, 3H),
2.03 (s, 3H); 13C NMR (100 MHz, CDCl3): δ
201.4, 201.3, 192.6, 174.5, 143.0, 141.2, 139.9, 137.9, 137.7, 136.2,
135.9, 135.7, 135.0, 134.7, 133.6, 132.8, 132.4, 131.9, 131.9, 130.1,
130.0, 129.2, 128.7, 128.6, 128.5, 128.4, 127.7, 127.1, 126.6, 122.2,
121.9, 121.1, 118.2, 106.9, 90.1, 64.4, 63.4, 52.0, 45.7, 39.6, 35.0,
21.0, 20.9; IR (KBr) ν: 3027, 2915, 2861, 1952, 1888, 1699,
1637, 1593, 1481, 1412, 1370, 1244, 1175, 1090, 1015, 939, 857, 761,
703 cm–1; MS (m/z): HRMS (ESI-TOF) calcd for C50H39NO4 ([M + H]+), 752.2568; found, 752.2504.

4.42 (2′S,4′R,4a′S,5′S,11a′S)-1′-(4-Chlorobenzyl)-4′-phenyl-2′,5′-di-m-tolyl-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(4p)
The product is obtained as a yellow solid,
60%, 0.451 g, mp 140–142 °C; 1H NMR (400 MHz,
CDCl3): δ 7.48 (t, J = 5.9 Hz, 2H),
7.43–7.35 (m, 6H), 7.26–7.19 (m, 4H), 7.09–7.02
(m, 4H), 6.96 (d, J = 4.0 Hz, 3H), 6.88–6.77
(m, 5H), 6.70 (d, J = 5.9 Hz, 1H), 6.65 (s, 1H),
5.40 (s, 1H), 4.87 (s, 1H), 3.90 (q, J = 15.2, 14.4
Hz, 2H), 3.67–3.60 (m, 2H), 3.50 (s, 1H), 2.18 (s, 3H), 2.06
(d, J = 13.3 Hz, 3H); 13C NMR (100 MHz,
CDCl3): δ 201.3, 201.2, 192.5, 174.4, 142.9, 138.1,
137.8, 135.7, 135.7, 135.0, 134.7, 133.6, 133.0, 132.0, 132.0, 130.2,
130.1, 128.6, 128.6, 128.5, 128.4, 127.7, 127.6, 127.5, 126.7, 124.6,
121.2, 118.2, 106.8, 89.8, 64.9, 63.4, 52.2, 45.5, 39.4, 35.3, 21.4;
IR (KBr) ν: 3066, 2940, 2855, 1949, 1872, 1740, 1702, 1636,
1593, 1486, 1417, 1368, 1247, 1196, 1145, 1073, 1010, 960, 876, 762,
701, 638 cm–1; MS (m/z): HRMS (ESI-TOF) calcd for C50H39ClNO4 ([M + H]+), 752.2568; found, 752.2588.

4.43 (2′S,4′R,4a′S,5′S,11a′S)-1′-Butyl-2′,5′-bis(3-fluorophenyl)-4′-phenyl-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(4q)
The product is obtained as a yellow solid,
76%, 0.526 g, mp 151–153 °C; 1H NMR (400 MHz,
CDCl3): δ 7.52–7.28 (m, 10H), 7.22 (d, J = 8.3 Hz, 1H), 7.11 (s, 1H), 7.03–6.87 (m, 7H),
6.75–6.68 (m, 1H), 6.62 (t, J = 8.6 Hz, 1H),
5.64 (s, 1H), 4.84 (d, J = 17.9 Hz, 1H), 3.80 (d, J = 13.9 Hz, 1H), 3.61–3.57 (m, 2H), 3.04–2.93
(m, 1H), 2.58 (br s, 1H), 1.50 (s, 1H), 1.30 (s, 1H), 1.15–1.07
(m, 2H), 0.76 (t, J = 7.1 Hz, 3H); 13C
NMR (100 MHz, CDCl3): δ 201.2, 201.0, 192.5, 175.3,
164.3, 161.8, 145.9, 145.8, 142.8, 141.0, 137.5, 135.4, 135.3, 134.9,
133.5, 132.1, 32.0, 130.3, 130.2, 129.6, 128.8, 128.6, 127.9, 126.5,
123.4, 123.3, 122.3, 122.0, 121.2, 118.5, 114.8, 114.6, 113.9, 113.7,
105.5, 92.0, 63.0, 50.1, 45.4, 40.0, 35.2, 29.1, 20.3, 13.8; IR (KBr)
ν: 3068, 2960, 2864, 1956, 1880, 1738, 1698, 1589, 1459, 1411,
1376, 1249, 1196, 1148, 1071, 1014, 936, 877, 768, 704, 630 cm–1; MS (m/z): HRMS
(ESI-TOF) calcd for C45H36F2NO4 ([M + H]+), 692.2612; found, 692.2608.

4.44 (2′S,4′R,4a′S,5′S,11a′S)-2′,5′-Bis(4-bromophenyl)-1′-butyl-4′-phenyl-1′,4a′,5′,11a′-tetrahydro-2′H-spiro[indene-2,3′-indeno[2′,1′:5,6]pyrano[2,3-b]pyridine]-1,3,6′(4′H)-trione
(4r)
The product is obtained as a yellow solid,
62%, 0.505 g, mp 134–136 °C; 1H NMR (400 MHz,
CDCl3): δ 7.51–7.36 (m, 10H), 7.19–7.09
(m, 7H), 6.95 (s, 2H), 6.85 (s, 2H), 5.60 (s, 1H), 4.81 (s, 1H), 3.72
(d, J = 13.0 Hz, 1H), 3.58–3.56 (m, 2H), 2.97–2.90
(m, 1H), 2.54 (br s, 1H), 1.47 (br s, 2H), 1.14–1.06 (m, 2H),
0.77 (t, J = 6.5 Hz, 3H3); 13C NMR (100 MHz, CDCl3): δ 201.3, 201.1, 192.6, 175.3,
142.7, 142.2, 141.0, 137.5, 135.4, 135.3, 135.1, 134.7, 133.5, 132.1,
132.1, 131.9, 131.8, 131.3, 131.0, 130.3, 130.0, 129.4, 128.8, 128.5,
127.9, 126.4, 123.5, 122.3, 122.1, 121.9, 121.3, 120.8, 118.5, 105.6,
91.9, 63.5, 63.0, 50.1, 45.5, 40.0, 34.9, 29.1, 20.3, 18.4, 13.9.;
IR (KBr) ν: 3064, 2951, 2862, 1895, 1700, 1632, 1591, 1478,
1411, 1369, 1250, 1195, 1072, 1009, 955, 888, 816, 761, 706 cm–1; MS (m/z): HRMS
(ESI-TOF) calcd for C45H38BrNO4 ([M
+ H]+), 814.0991; found, 814.1009.

4.45 General
Procedure for the Synthesis of Dispiro
Compounds 5a–5m
A mixture of α,β-unsaturated N-arylaldimine (0.5 mmol) and 2,2′-(arylmethylene)bis(indene-1,3-dione)
(0.5 mmol) in dry acetonitrile (10.0 mL) was stirred at room temperature
for 10 h. The solvent was removed by rotatory evaporation at reduced
pressure. The residue was subjected with silicon column chromatography
with mixed petroleum ether and ethyl acetate (v/v = 2:1) as an eluant
to give a pure product for analysis.

4.46 2′,4′-Diphenyl-6′-(phenylamino)dispiro[indene-2,1′-cyclohexane-3′,2″-indene]-1,1″,3,3″-tetraone
(5a)
The product is obtained as a yellow solid,
86%, 0.253 g, mp 179–183 °C; 1H NMR (400 MHz,
CDCl3): δ trans-isomer: 8.11 (d, J = 7.3 Hz, 1H), 7.73 (m, J = 7.2 Hz, 1H), 7.65–7.34
(m, 6H), 7.13–6.86 (m, 7H), 6.79–6.56 (m, 7H), 6.55–6.42
(m, 1H), 4.99–4.94 (m, 2H), 4.31–4.27 (m, 1H), 4.07
(d, J = 12.1 Hz, 1H), 3.47–3.39 (m, 1H), 2.04
(d, J = 13.5 Hz, 1H); cis-isomer: 7.96 (d, J = 7.3 Hz, 1H), 7.65–7.34 (m, 7H), 4.70 (s, 1H),
4.65 (d, J = 11.9 Hz, 1H), 4.20 (d, J = 12.5 Hz, 1H), 3.05 (d, J = 11.5 Hz, 1H), 2.34
(d, J = 13.4 Hz, 1H); 13C NMR (100 MHz,
CDCl3): δ 203.4, 203.1, 202.7, 202.6, 202.2, 201.5,
201.3, 201.1, 146.1, 144.0, 143.1, 142.8, 142.6, 142.3, 141.6, 141.4,
139.1, 139.0, 135.6, 135.3, 135.1, 135.0, 134.9, 134.8, 134.0, 133.6,
130.9, 129.1, 129.0, 128.7, 128.6, 128.4, 128.0, 128.0, 127.8, 127.6,
127.4, 127.3, 127.0, 126.9, 122.9, 122.7, 122.5, 122.4, 122.3, 122.2,
115.4, 115.2, 114.7, 63.7, 63.3, 62.6, 61.9, 58.1, 56.1, 55.4, 53.7,
53.0, 51.9, 45.6, 43.6, 31.3, 31.2; IR (KBr) ν: 3039, 1704,
1595, 1499, 1446, 1341, 1248, 1155, 1115, 1031, 958, 884, 760 cm–1; MS (m/z): HRMS
(ESI-TOF) calcd for C40H30NO4 ([M
+ H]+), 588.2175; found, 588.2177.

4.47 4′-Phenyl-6′-(phenylamino)-2′-(p-tolyl)dispiro[indene-2,1′-cyclohexane-3′,2″-indene]-1,1″,3,3″-tetraone
(5b)
The product is obtained as a yellow solid,
89%, 0.268 g, mp 184–189 °C; 1H NMR (400 MHz,
CDCl3): δ trans-isomer: 8.10 (d, J = 8.4 Hz, 1H), 7.73 (t, J = 7.0 Hz, 1H), 7.64–7.36
(m, 6H), 7.08–6.88 (m, 7H), 6.66–6.45 (m, 7H), 4.95
(d, J = 16.0 Hz, 2H), 4.27 (d, J = 8.8 Hz, 1H), 4.06 (d, J = 12.8 Hz, 1H), 3.45–3.36
(m, 1H), 2.01 (d, J = 14.0 Hz, 1H), 1.98–1.80
(m, 3H); cis-isomer: 7.96 (d, J = 7.6 Hz, 1H), 7.64–7.36
(m, 7H), 4.67–4.63 (m, 2H), 4.19 (d, J = 11.2
Hz, 1H), 3.09–2.98 (m, 1H), 2.33 (d, J = 9.6
Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 203.5,
203.2, 202.8, 202.7, 202.2, 201.5, 201.2, 146.1, 144.0, 143.1, 142.8,
142.6, 142.4, 141.6, 141.4, 139.1, 139.1, 136.8, 135.5, 135.2, 135.0,
134.9, 134.8, 134.7, 131.0, 130.8, 130.5, 130.2, 129.1, 129.0, 128.6,
128.5, 128.3, 127.9, 127.9, 127.0, 126.9, 122.9, 122.8, 122.7, 122.4,
122.3, 122.2, 118.8, 118.4, 115.4, 115.2, 114.6, 110.0, 63.8, 63.4,
62.7, 61.9, 56.1, 53.7, 52.5, 51.4, 45.6, 43.7, 31.3, 31.2, 20.7,
20.6; IR (KBr) ν: 3026, 1704, 1596, 1499, 1347, 1248, 1153,
1032, 959, 882, 754 cm–1; MS (m/z): HRMS (ESI-TOF) calcd for C41H32NO4 ([M + H]+), 602.2331; found, 602.2330.

4.48 2′-(2-Fluorophenyl)-4′-phenyl-6′-(phenylamino)dispiro[indene-2,1′-cyclohexane-3′,2″-indene]-1,1″,3,3″-tetraone
(5c)
The product is obtained as a yellow solid,
92%, 0.289 g, mp 166–169 °C; 1H NMR (400 MHz,
CDCl3): δ trans-isomer: 8.11 (d, J = 8.0 Hz, 1H), 7.74 (t, J = 8.0 Hz, 1H), 7.67–7.43
(m, 6H), 7.11–6.96 (m, 8H), 6.79–6.36 (m, 7H), 5.07–4.96
(m, 2H), 4.86 (s, 1H), 3.92 (d, J = 16.0 Hz, 1H),
3.57–3.48 (m, 1H), 2.01 (d, J = 16.0 Hz, 1H);
cis-isomer: 7.97 (d, J = 8.0 Hz, 1H), 7.67–7.43
(m, 7H), 6.79–6.36 (m, 8H), 5.26 (s, 1H), 4.66 (t, J = 12.6 Hz, 1H), 4.36 (d, J = 12.8 Hz,
1H), 4.26 (d, J = 12.8 Hz, 1H), 3.20–3.11
(m, 1H), 2.38 (d, J = 16.8 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 202.2, 202.2, 202.1, 202.1,
202.1, 201.6, 201.4, 158.4, 146.0, 143.9, 142.5, 142.3, 141.3, 138.9,
135.6, 135.1, 135.0, 132.3, 129.1, 129.0, 128.8, 128.6, 128.0, 128.0,
127.0, 122.9, 122.8, 122.5, 122.3, 119.0, 115.5, 115.2, 114.7, 62.7,
62.5, 56.0, 54.2, 45.4, 43.6, 42.4, 31.6, 31.4; IR (KBr) ν:
3049, 2093, 1705, 1595, 1496, 1447, 1342, 1247, 1102, 957, 885, 760
cm–1; MS (m/z):
HRMS (ESI-TOF) calcd for C40H28FNNaO4 ([M + Na]+), 628.1900; found, 628.1902.

4.49 4′-((3-Chlorophenyl)amino)-2′-(2-fluorophenyl)-6′-phenyldispiro[indene-2,1′-cyclohexane-3′,2″-indene]-1,1″,3,3″-tetraone
(5d)
The product is obtained as a yellow solid,
90%, 0.298 g, mp 186–187 °C; 1H NMR (600 MHz,
CDCl3): δ trans-isomer: 8.11 (d, J = 7.5 Hz, 1H), 7.76 (t, J = 7.1 Hz, 1H), 7.62–7.52
(m, 3H), 7.49–7.43 (m, 3H), 7.11–7.07 (m, 2H), 7.04–6.91
(m, 4H), 6.86–6.69 (m, 2H), 6.59–6.54 (m, 3H), 6.47–6.33
(m, 2H), 5.03 (d, J = 13.7 Hz, 1H), 4.95 (t, J = 18.6 Hz, 1H), 4.85 (s, 1H), 4.03 (d, J = 11.9 Hz, 1H), 3.57–3.51 (m, 1H), 1.99 (d, J = 15.2 Hz, 1H); cis-isomer: 8.00 (d, J = 7.1 Hz,
1H), 7.68 (t, J = 7.7 Hz, 1H), 7.49–7.43 (m,
4H), 6.86–6.69 (m, 3H), 6.47–6.33 (m, 4H), 5.24 (s,
1H), 4.61 (br s, 1H), 4.38 (d, J = 12.3 Hz, 2H),
3.19–3.13 (m, 1H), 2.36 (d, J = 16.2 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 202.1, 201.9,
201.5, 201.3, 160.9, 158.4, 147.2, 143.8, 142.4, 142.2, 141.3, 138.7,
135.8, 135.6, 135.3, 135.2, 135.0, 134.8, 134.7, 132.3, 130.1, 130.0,
129.3, 129.2, 128.7, 128.6, 128.0, 127.1, 123.1, 123.0, 122.8, 122.5,
122.3, 118.8, 118.2, 115.5, 115.3, 114.9, 114.2, 113.2, 112.7, 62.6,
62.4, 62.3, 55.5, 53.7, 53.4, 45.1, 43.6, 42.4, 31.5, 31.3; IR (KBr)
ν: 3063, 1706, 1591, 1486, 1343, 1246, 1088, 991, 958, 882,
763 cm–1; MS (m/z): HRMS (ESI-TOF) calcd for C40H27ClFNNaO4 ([M + Na]+), 662.1510; found, 662.1503.

4.50 2′-(2-Chlorophenyl)-4′-phenyl-6′-(phenylamino)dispiro[indene-2,1′-cyclohexane-3′,2″-indene]-1,1″,3,3″-tetraone
(5e)
The product is obtained as a yellow solid,
88%, 0.273 g, mp 162–164 °C; 1H NMR (400 MHz,
CDCl3): δ trans-isomer: 8.10 (d, J = 6.8 Hz, 1H), 7.73 (t, J = 6.8 Hz, 1H), 7.62 (d, J = 8.0 Hz, 1H), 7.57–7.43 (m, 5H), 7.15–6.83
(m, 9H), 6.69–6.47 (m, 5H), 5.15–5.01 (m, 3H), 3.80
(d, J = 12.0 Hz, 1H), 3.60–3.51 (m, 1H), 2.02
(d, J = 13.6 Hz, 1H); cis-isomer: 7.92 (d, J = 6.8 Hz, 1H), 7.62 (d, J = 8.0 Hz, 2H),
5.43 (s, 1H), 4.73 (t, J = 11.4 Hz, 1H), 4.37 (d, J = 12.4 Hz, 1H), 4.26 (d, J = 11.6 Hz,
1H), 3.28–3.18 (m, 1H), 2.40 (d, J = 13.6
Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 202.3,
202.0, 201.6, 201.1, 149.8, 146.1, 144.0, 142.5, 142.4, 141.5, 138.9,
135.5, 135.3, 135.1, 135.0, 134.7, 132.7, 131.7, 131.6, 130.0, 129.7,
129.1, 129.1, 129.0, 128.8, 128.5, 128.4, 127.9, 127.0, 125.9, 125.5,
122.9, 122.6, 122.5, 122.3, 119.0, 118.5, 115.2, 114.7, 63.2, 62.3,
62.2, 62.0, 55.8, 54.6, 47.3, 45.6, 45.1, 43.6, 32.1, 31.4, 15.0;
IR (KBr) ν: 3058, 1739, 1704, 1597, 1501, 1325, 1247, 1041,
761 cm–1; MS (m/z): HRMS (ESI-TOF) calcd for C40H29ClNO4 ([M + H]+), 622.1785; found, 622.1788.

4.51 2′-(2-Chlorophenyl)-4′-((3-chlorophenyl)amino)-6′-phenyldispiro[indene-2,1′-cyclohexane-3′,2″-indene]-1,1″,3,3″-tetraone
(5f)
The product is obtained as a yellow solid,
91%, 0.298 g, mp 166–170 °C; 1H NMR (400 MHz,
CDCl3): δ trans-isomer: 8.10 (d, J = 9.2 Hz, 1H), 7.75 (t, J = 6.4 Hz, 1H), 7.68–7.42
(m, 6H), 7.15–6.81 (m, 8H), 6.69–6.52 (m, 2H), 6.47
(d, J = 8.0 Hz, 1H), 6.37 (t, J =
9.4 Hz, 2H), 5.12–5.08 (m, 2H), 4.99 (t, J = 10.4 Hz, 1H), 3.90 (d, J = 11.2 Hz, 1H), 3.62–3.52
(m, 1H), 2.00 (d, J = 15.2 Hz, 1H); cis-isomer: 7.96
(d, J = 8.4 Hz, 1H), 7.68–7.42 (m, 7H), 6.69–6.52
(m, 3H), 5.41 (s, 1H), 4.70–4.64 (m, 1H), 4.42–4.38
(m, 2H), 3.28–3.18 (m, 1H), 2.40–2.36 (m, 1H); 13C NMR (100 MHz, CDCl3): δ 203.0, 202.1,
201.8, 201.3, 201.1, 201.0, 199.8, 147.3, 147.3, 143.9, 142.8, 142.7,
142.5, 142.3, 142.2, 141.5, 138.8, 138.7, 135.6, 135.3, 135.1, 134.8,
134.8, 134.6, 132.7, 132.1, 131.6, 131.5, 130.1, 130.0, 129.8, 129.0,
128.8, 128.5, 128.0, 127.1, 125.9, 123.0, 122.9, 122.5, 118.3, 115.0,
114.3, 114.2, 112.7, 63.1, 62.2, 62.0, 61.9, 55.4, 47.3, 47.2, 45.6,
45.5, 44.9, 31.4; IR (KBr) ν: 33 064, 1739, 1704, 1593,
1480, 1327, 1246, 1159, 1084, 1039, 989, 852, 764 cm–1; MS (m/z): HRMS (ESI-TOF) calcd
for C40H28Cl2NO4 ([M +
H]+), 656.1395; found, 656.1390.

4.52 2′-(2-Chlorophenyl)-4′-((4-methoxyphenyl)amino)-6′-phenyldispiro[indene-2,1′-cyclohexane-3′,2″-indene]-1,1″,3,3″-tetraone
(5g)
The product is obtained as a yellow solid,
88%, 0.287 g, mp 158–160 °C; 1H NMR (400 MHz,
CDCl3): δ trans-isomer: 8.08 (d, J = 7.4 Hz, 1H), 7.72 (t, J = 7.3 Hz, 1H), 7.61 (d, J = 7.7 Hz, 1H), 7.57–7.41 (m, 5H), 7.15–7.09
(m, 2H), 7.02–6.83 (m, 5H), 6.68–6.43 (m, 6H), 5.14
(d, J = 12.3 Hz, 1H), 5.06 (s, 1H), 4.94–4.89
(m, 1H), 3.65 (s, 3H), 3.56–3.47 (m, 2H), 2.02 (d, J = 14.9 Hz, 1H); cis-isomer: 7.89 (d, J = 6.8 Hz, 1H), 7.05 (d, J = 7.7 Hz, 1H), 5.41 (s,
1H), 4.32 (d, J = 10.9 Hz, 1H), 4.00 (d, J = 13.3 Hz, 1H), 3.68 (s, 1H), 3.60 (s, 3H), 3.26–3.16
(m, 1H), 2.39 (d, J = 12.9 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 202.3, 201.9, 201.7, 201.1,
153.1, 144.1, 142.4, 142.4, 141.5, 140.0, 138.9, 135.3, 135.0, 134.6,
132.7, 131.7, 129.7, 129.0, 128.8, 128.5, 127.9, 127.0, 125.4, 122.8,
122.7, 122.5, 122.3, 117.2, 117.1, 114.6, 114.5, 63.3, 62.3, 56.4,
56.2, 55.7, 55.5, 47.4, 47.2, 43.6, 43.4, 31.8; IR (KBr) ν:
3040, 1739, 1704, 1593, 1513, 1447, 1329, 1248, 1177, 1130, 1032,
825, 766 cm–1; MS (m/z): HRMS (ESI-TOF) calcd for C41H30ClNNaO5 ([M + Na]+), 674.1710; found, 674.1705.

4.53 2′-(4-Bromophenyl)-4′-phenyl-6′-(phenylamino)dispiro[indene-2,1′-cyclohexane-3′,2″-indene]-1,1″,3,3″-tetraone
(5h)
The product is obtained as a yellow solid,
87%, 0.290 g, mp 180–182 °C; 1H NMR (400 MHz,
CDCl3): δ trans-isomer: 8.09 (d, J = 7.6 Hz, 1H), 7.75 (t, J = 7.6 Hz, 1H), 7.68–7.35
(m, 6H), 7.05–6.80 (m, 9H), 6.68–6.41 (m, 5H), 4.92
(d, J = 12.4 Hz, 2H), 4.28–4.23 (m, 1H), 4.00
(d, J = 11.6 Hz, 1H), 3.41–3.32 (m, 1H), 2.00
(d, J = 14.0 Hz, 1H); cis-isomer: 7.96 (d, J = 7.6 Hz, 1H), 7.68–7.35 (m, 7H), 6.68–6.41
(m, 6H), 4.68 (d, J = 1.6 Hz, 1H), 4.60 (s, 1H),
3.45–3.36 (m, 1H), 4.15 (d, J = 11.6 Hz, 1H),
3.04–2.94 (m, 1H), 2.32 (d, J = 13.6 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 203.2, 202.8,
202.6, 202.4, 201.9, 201.3, 201.1, 200.8, 146.0, 145.9, 143.8, 142.8,
142.4, 142.3, 142.3, 141.5, 141.4, 138.8, 138.7, 135.8, 135.5, 135.3,
135.3, 135.1, 133.4, 132.9, 132.5, 131.0, 130.8, 129.1, 129.0, 128.5,
128.4, 128.0, 128.0, 127.1, 127.1, 123.0, 122.9, 122.6, 122.5, 122.4,
122.3, 121.6, 119.0, 118.6, 115.3, 114.7, 63.6, 63.2, 62.4, 61.7,
56.2, 53.9, 51.8, 50.6, 45.9, 43.9, 31.3, 31.2; IR (KBr) ν:
3053, 1737, 1701, 1595, 1494, 1332, 1248, 1078, 1006, 959, 762 cm–1; MS (m/z): HRMS
(ESI-TOF) calcd for C40H29BrNO4 ([M
+ H]+), 666.1280; found, 666.1274.

4.54 2′-(2-Bromophenyl)-4′-phenyl-6′-(phenylamino)dispiro[indene-2,1′-cyclohexane-3′,2″-indene]-1,1″,3,3″-tetraone
(5i)
The product is obtained as a yellow solid,
90%, 0.300 g, mp 163–164 °C; 1H NMR (400 MHz,
CDCl3): δ trans-isomer: 8.09 (d, J = 3.6 Hz, 1H), 7.73 (t, J = 7.0 Hz, 1H), 7.66–7.42
(m, 6H), 7.16–6.90 (m, 9H), 6.68–6.49 (m, 5H), 5.14
(d, J = 10.0 Hz, 1H), 5.08–5.03 (m, 2H), 3.74
(d, J = 12.8 Hz, 1H), 3.55–3.51 (m, 1H), 2.03
(d, J = 14.8 Hz, 1H); cis-isomer: 7.90 (d, J = 8.4 Hz, 1H), 7.66–7.42 (m, 7H), 5.37 (s, 1H),
4.79–4.74 (m, 1H), 4.37 (d, J = 7.6 Hz, 1H),
4.25 (d, J = 10.8 Hz, 1H), 3.30–3.19 (m, 1H),
2.42 (d, J = 12.8 Hz, 1H); 13C NMR (100
MHz, CDCl3): δ 203.1, 202.3, 202.1, 202.0, 201.3,
201.0, 200.7, 199.9, 146.1, 144.1, 143.0, 142.7, 142.4, 142.3, 141.6,
139.0, 138.9, 135.5, 135.3, 135.2, 135.1, 135.0, 134.0, 133.6, 133.5,
133.2, 132.8, 131.7, 129.2, 129.1, 129.0, 128.9, 128.7, 128.6, 128.0,
127.9, 127.0, 126.5, 126.1, 125.9, 125.7, 122.9, 122.9, 122.6, 122.5,
122.3, 119.0, 118.5, 115.5, 115.2, 114.7, 63.5, 62.1, 62.1, 55.8,
54.7, 50.2, 48.3, 45.1, 43.6, 32.3, 31.4; IR (KBr) ν: 3056,
1737, 1703, 1595, 1501, 1320, 1246, 1025, 760 cm–1; MS (m/z): HRMS (ESI-TOF) calcd
for C40H29BrNO4 ([M + H]+), 666.1280; found, 666.1272.

4.55 2′-(2-Bromophenyl)-4′-phenyl-6′-(p-tolylamino)dispiro[indene-2,1′-cyclohexane-3′,2″-indene]-1,1″,3,3″-tetraone
(5j)
The product is obtained as a yellow solid,
92%, 0.313 g, mp 160–161 °C; 1H NMR (400 MHz,
CDCl3): δ trans-isomer: 8.08 (d, J = 8.1 Hz, 1H), 7.72 (t, J = 8.1 Hz, 1H), 7.66–7.61
(m, 1H), 7.57–7.41 (m, 5H), 7.15–6.84 (m, 9H), 6.61–6.52
(m, 4H), 5.14 (d, J = 13.2 Hz, 1H), 5.04–4.98
(m, 2H), 3.60 (d, J = 12.7 Hz, 1H), 3.55–3.47
(m, 1H), 2.13 (s, 3H), 2.05–2.00 (m, 1H); cis-isomer: 7.89
(d, J = 5.4 Hz, 1H), 7.66–7.61 (m, 2H), 6.73
(d, J = 8.0 Hz, 1H), 6.42 (d, J =
8.4 Hz, 1H), 5.36 (s, 1H), 4.72 (br s, 1H), 4.33 (d, J = 16.2 Hz, 1H), 4.10 (d, J = 11.1 Hz, 1H), 3.27–3.17
(m, 1H), 2.40 (d, J = 12.7 Hz, 1H), 2.07 (s, 1H); 13C NMR (100 MHz, CDCl3): δ 202.3, 202.1,
201.4, 201.0, 144.1, 143.8, 142.5, 142.5, 141.7, 139.0, 135.4, 135.1,
133.6, 133.2, 132.8, 129.6, 129.2, 128.9, 128.7, 128.4, 127.9, 127.0,
126.1, 125.8, 122.8, 122.6, 122.3, 115.6, 115.5, 63.5, 62.2, 55.4,
50.2, 50.1, 43.7, 32.1, 20.3; IR (KBr) ν: 2918, 1740, 1705,
1598, 1516, 1326, 1247, 1024, 817, 762, 700 cm–1; MS (m/z): HRMS (ESI-TOF) calcd
for C41H31BrNO4 ([M + H]+), 680.1436; found, 680.1420.

4.56 2′-(2-Bromophenyl)-4′-((4-methoxyphenyl)amino)-6′-phenyldispiro[indene-2,1′-cyclohexane-3′,2″-indene]-1,1″,3,3″-tetraone
(5k)
The product is obtained as a yellow solid,
90%, 0.313 g, mp 154–156 °C; 1H NMR (400 MHz,
CDCl3): δ trans-isomer: 8.07 (d, J = 7.8 Hz, 1H), 7.72 (t, J = 7.3 Hz, 1H), 7.64 (d, J = 8.0 Hz, 1H), 7.57–7.41 (m, 5H), 7.16–6.91
(m, 7H), 6.62–6.45 (m, 6H), 5.15 (d, J = 13.3
Hz, 1H), 5.03 (s, 1H), 4.94 (t, J = 9.6 Hz, 1H),
3.66 (s, 3H), 3.53–3.46 (m, 2H), 2.03 (d, J = 12.9 Hz, 1H); cis-isomer: 7.87 (d, J = 8.6 Hz,
1H), 7.16–6.91 (m, 8H), 5.35 (s, 1H), 4.68 (br s, 1H), 4.31
(d, J = 11.9 Hz, 1H), 3.98 (d, J = 13.2 Hz, 1H), 3.60 (s, 3H), 3.27–3.18 (m, 1H), 2.39 (d, J = 12.8 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 202.3, 202.0, 201.5, 201.0, 153.2, 144.1, 142.5,
142.4, 141.7, 140.0, 139.0, 135.4, 135.1, 135.0, 133.5, 133.2, 132.8,
129.2, 128.9, 127.9, 127.0, 125.8, 122.8, 122.6, 117.2, 114.6, 63.6,
62.2, 56.4, 55.7, 43.6, 32.0; IR (KBr) ν: 3038, 1740, 1705,
1593, 1511, 1445, 1329, 1245, 1184, 1127, 1031, 829, 766 cm–1; MS (m/z): HRMS (ESI-TOF) calcd
for C41H31BrNO5 ([M + H]+), 696.1386; found, 696.1373.

4.57 2′-(2-Bromophenyl)-4′-((4-methoxyphenyl)amino)-6′-(p-tolyl)dispiro[indene-2,1′-cyclohexane-3′,2″-indene]-1,1″,3,3″-tetraone
(5l)
The product is obtained as a yellow solid,
93%, 0.330 g, mp 160–163 °C; 1H NMR (400 MHz,
CDCl3): δ trans-isomer: 8.07 (d, J = 7.8 Hz, 1H), 7.73–7.61 (m, 2H), 7.56–7.42 (m, 5H),
7.07–7.00 (m, 4H), 6.85 (d, J = 6.9 Hz, 2H),
6.60–6.51 (m, 6H), 5.10 (d, J = 15.0 Hz, 1H),
5.01–4.96 (m, 2H), 3.60 (s, 3H), 3.57–3.44 (m, 2H),
2.13 (s, 3H), 1.99 (d, J = 15.3 Hz, 1H); cis-isomer:
7.88 (d, J = 7.6 Hz, 1H), 6.72 (d, J = 8.0 Hz, 2H), 6.41 (d, J = 6.6 Hz, 2H), 5.33 (s,
1H), 4.72 (br s, 1H), 4.28 (d, J = 12.9 Hz, 1H),
4.08 (d, J = 12.2 Hz, 1H), 3.06 (s, 3H), 3.23–3.14
(m, 1H), 2.36 (d, J = 13.6 Hz, 1H), 2.13 (s, 1H),
2.07 (s, 3H); 13C NMR (100 MHz, CDCl3): δ
202.5, 202.1, 201.5, 201.2, 158.3, 144.1, 143.8, 142.6, 142.5, 141.7,
135.4, 135.1, 135.0, 133.6, 133.2, 132.7, 131.1, 130.2, 129.6, 128.4,
125.8, 122.8, 113.3, 63.5, 62.2, 55.0, 50.2, 32.5, 20.3; IR (KBr)
ν: 2924, 1740, 1705, 1602, 1512, 1464, 1337, 1248, 1175, 1122,
1028, 835, 763, 726 cm–1; MS (m/z): HRMS (ESI-TOF) calcd for C42H33BrNO5 ([M + H]+), 710.1542; found,
710.1531.

4.58 2′-(2-Bromophenyl)-4′-(4-methoxyphenyl)-6′-((4-methoxyphenyl)amino)dispiro[indene-2,1′-cyclohexane-3′,2″-indene]-1,1″,3,3″-tetraone
(5m)
The product is obtained as a yellow solid,
88%, 0.319 g, mp 137–142 °C; 1H NMR (400 MHz,
CDCl3): δ trans-isomer: 8.06 (d, J = 7.4 Hz, 1H), 7.73–7.60 (m, 2H), 7.56–7.39 (m, 5H),
7.08–6.99 (m, 4H), 6.62–6.45 (m, 8H), 5.12–5.08
(m, 1H), 5.00 (s, 1H), 4.92 (t, J = 15.0 Hz, 1H),
3.66 (s, 3H), 3.61 (s, 3H), 3.52–3.43 (m, 2H), 1.99 (d, J = 13.1 Hz, 1H); cis-isomer: 7.86 (d, J = 6.6 Hz, 1H), 5.32 (s, 1H), 4.67 (br s, 1H), 4.26 (d, J = 11.6 Hz, 1H), 3.97 (d, J = 10.8 Hz, 1H), 3.19
(d, J = 10.8 Hz, 1H), 2.35 (d, J = 7.8 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ
202.5, 202.0, 201.5, 201.2, 158.3, 153.1, 144.1, 142.6, 142.4, 141.7,
140.1, 135.7, 135.4, 135.1, 135.0, 133.6, 133.2, 132.7, 131.5, 131.1,
130.2, 129.9, 128.7, 126.1, 125.8, 122.8, 122.5, 122.3, 117.2, 114.6,
114.4, 113.3, 63.6, 62.3, 56.4, 55.7, 55.6, 55.0, 55.0, 50.3, 50.2,
44.5, 42.8, 32.3; IR (KBr) ν: 3061, 2930, 2830, 1738, 1703,
1598, 1511, 1458, 1343, 1242, 1174, 1104, 1034, 960, 827, 765 cm–1; MS (m/z): HRMS
(ESI-TOF) calcd for C42H33BrNO6 ([M
+ H]+), 726.1491; found, 726.1485.

4.59 2′-(2-Bromophenyl)-4′-(4-fluorophenyl)-6′-((4-methoxyphenyl)amino)dispiro[indene-2,1′-cyclohexane-3′,2″-indene]-1,1″,3,3″-tetraone
(5n)
The product is obtained as a yellow solid,
85%, 0303 g, mp 146–148 °C; 1H NMR (400 MHz,
CDCl3): δ trans-isomer: 8.08 (d, J = 9.0 Hz, 1H), 7.75–7.69 (m, 2H), 7.62–7.39 (m, 5H),
7.12–6.90 (m, 7H), 6.67–6.47 (m, 5H), 5.14 (d, J = 12.8 Hz, 1H), 5.06–4.01 (m, 2H), 3.70 (d, J = 12.7 Hz, 1H), 3.56–3.48 (m, 1H), 1.99 (d, J = 15.8 Hz, 1H); cis-isomer: 7.90 (d, J = 8.3 Hz, 1H), 7.12–6.90 (m, 8H), 5.33 (s, 1H), 4.74 (br
s, 1H), 4.36 (d, J = 14.0 Hz, 1H), 4.23 (d, J = 12.8 Hz, 1H), 3.27–3.17 (m, 1H), 2.37 (d, J = 11.0 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 202.3, 202.0, 201.3, 201.0, 162.8, 160.4, 153.2,
144.0, 142.5, 142.4, 141.6, 139.9, 135.4, 135.3, 135.2, 135.1, 134.8,
133.4, 133.2, 132.6, 130.8, 130.7, 130.4, 128.7, 126.1, 125.8, 122.8,
122.6, 122.3, 117.2, 114.8, 114.6, 63.5, 62.1, 56.2, 55.6, 50.2, 50.2,
32.1.; IR (KBr) ν: 3064, 1740, 1705, 1595, 1511, 1339, 1245,
1169, 1121, 1030, 832, 764, 728 cm–1; MS (m/z): HRMS (ESI-TOF) calcd for C41H30BrFNO5 ([M + H]+), 714.1291;
found, 714.1280.

Supporting Information Available
The
Supporting Information is
available free of charge on the ACS Publications website at DOI: 10.1021/acsomega.9b01960.Copies of the 1H and 13C{1H} NMR spectra for all new
products (PDF)

Crystallographic data of compounds 3e (CCDC
1917510), 3g (CCDC 1917511), 3i (CCDC 1917512), 3l (CCDC 1917513), 3p (CCDC 1917514), 4f (CCDC 1917515), 4m (CCDC 1917516), 5g (CCDC
1917517), and 5i (CCDC 1917518) have been deposited at
the Cambridge Crystallographic Database Center (http://www.ccdc.cam.ac.uk)
(CIF)



Supplementary Material
ao9b01960_si_001.pdf

 ao9b01960_si_002.cif

 The authors declare no
competing financial interest.

Acknowledgments
This
work was financially supported by the National
Natural Science Foundation of China (nos. 21572196), the Priority
Academic Program Development of Jiangsu Higher Education Institutions
(no. BK2013016).
==== Refs
References
a Zhang J. ; El-Shabrawy A.-R. O. ; El-Shanawany M. A. ; Schiff P. L. ; Slatkin D. J. 
New azafluorene
alkaloids from Oxandra
xylopioides . J. Nat. Prod. 
1987 , 50 , 800 –806 . 10.1021/np50053a005 . b Nugiel D. A. ; Etzkorn A.-M. ; Vidwans A. ; Benfield P. A. ; Boisclair M. ; Burton C. R. ; Cox S. ; Czerniak P. M. ; Doleniak D. ; Seitz S. P. 
Indenopyrazoles as Novel Cyclin Dependent Kinase (CDK)
Inhibitors . J. Med. Chem. 
2001 , 44 , 1334 –1336 . 10.1021/jm0100032 .11311054  c Frédérick R. ; Dumont W. ; Ooms F. ; Aschenbach L. ; Van der Schyf C. J. ; Castagnoli N. ; Wouters J. ; Krief A. 
Synthesis,
Structural Reassignment, and Biological Activity of Type B MAO Inhibitors
Based on the 5H-Indeno[1,2-c]pyridazin-5-one Core . J. Med. Chem. 
2006 , 49 , 3743 –3747 . 10.1021/jm051091j .16759116 
a Miri R. ; Javidnia K. ; Hemmateenejad B. ; Azarpira A. ; Amirghofran Z. 
Synthesis,
cytotoxicity, QSAR, and
intercalation study of new diindenopyridine derivatives . Bioorg. Med. Chem. 
2004 , 12 , 2529 –2536 . 10.1016/j.bmc.2004.03.032 .15110835  b Safak C. ; Simsek R. ; Altas Y. ; Boydag S. ; Erol K. 
2-Methyl-3-acetyl-4-aryl-5-oxo-1,4-dihydro-5H-indeno
(1,2-b) pyridine derivative studies and their calcium antagonistic
activities . Boll. Chim. Farm. 
1997 , 136 , 665 –669 .9534263 
Nicolaou K. C. ; Montagnon T. ; Vassilikogiannakis G. ; Mathison C. J. N. 
The Total Synthesis
of Coleophomones B, C, and D . J. Am. Chem. Soc. 
2005 , 127 , 8872 –8888 . 10.1021/ja0509984 .15954796 
a Addla D. ; Bhima ; Sridhar B. ; Devi A. ; Kantevari S. 
Design, synthesis
and antimicrobial evaluation of novel 1-benzyl 2-butyl-4-chloroimidazole
embodied 4-azafluorenones via molecular hybridization approach . Bioorg. Med. Chem. Lett. 
2012 , 22 , 7475 –7480 . 10.1016/j.bmcl.2012.10.042 .23147074  b Chakrabarty S. ; Croft M. S. ; Marko M. G. ; Moyna G. 
Synthesis and evaluation
as potential anticancer agents of novel tetracyclic indenoquinoline
derivatives . Bioorg. Med. Chem. 
2013 , 21 , 1143 –1149 . 10.1016/j.bmc.2012.12.026 .23357037  c Muscia G. C. ; Buldain G. Y. ; Asís S. E. 
Design,
synthesis and evaluation of acridine and fused-quinoline derivatives
as potential anti-tuberculosis agents . Eur.
J. Med. Chem. 
2014 , 73 , 243 –249 . 10.1016/j.ejmech.2013.12.013 .24412719 
Nagarajan M. ; Morrell A. ; Fort B. C. ; Meckley M. R. ; Antony S. ; Kohlhagen G. ; Pommier Y. ; Cushman M. 
Synthesis and anticancer
activity of simplified indenoisoquinoline topoisomerase I inhibitors
lacking substituents on the aromatic rings . J. Med. Chem. 
2004 , 47 , 5651 10.1021/jm040025z .15509164 
a Pizzirani D. ; Roberti M. ; Grimaudo S. ; Di Cristina A. ; Pipitone R. M. ; Tolomeo M. ; Recanatini M. 
Identification
of Biphenyl-Based Hybrid Molecules Able To Decrease the Intracellular
Level of Bcl-2 Protein in Bcl-2 Overexpressing Leukemia Cells . J. Med. Chem. 
2009 , 52 , 6936 –6940 . 10.1021/jm900907s .19764793 
Wu X. ; Li X. ; Li Z. ; Yu Y. ; You Q. ; Zhang X. 
Discovery
of Nonquinone Substrates for NAD(P)H: Quinone Oxidoreductase 1 (NQO1)
as Effective Intracellular ROS Generators for the Treatment of Drug-Resistant
Non-Small-Cell Lung Cancer . J. Med. Chem. 
2018 , 61 , 11280 –11297 . 10.1021/acs.jmedchem.8b01424 .30508483 
a Huang H.-H. ; Prabhakar C. ; Tang K.-C. ; Chou P.-T. ; Huang G.-J. ; Yang J.-S. 
Ortho-Branched
Ladder-Type Oligophenylenes
with Two-Dimensionally π-Conjugated Electronic Properties . J. Am. Chem. Soc. 
2011 , 133 , 8028 –8039 . 10.1021/ja202144v .21526823  b Gómez-Esteban S. ; Benito-Hernandez A. ; Termine R. ; Hennrich G. ; Navarrete J. T. L. ; Ruiz Delgado M. C. ; Golemme A. ; Gómez-Lor B. 
High-Mobility
Self-Assembling Truxenone-Based n-Type Organic Semiconductors . Chem.—Eur. J. 
2018 , 24 , 3576 –3583 . 10.1002/chem.201705760 .29271517  c Sanguinet L. ; Williams J. C. ; Yang Z. ; Twieg R. J. ; Mao G. ; Singer K. D. ; Wiggers G. ; Petschek R. G. 
Synthesis and Characterization of New Truxenones for
Nonlinear Optical Applications . Chem. Mater. 
2006 , 18 , 4259 –4269 . 10.1021/cm0601887 . d Chaudhri N. ; Grover N. ; Sankar M. 
Nickel-Induced Skeletal Rearrangement
of Free Base trans-Chlorins into Monofused NiII-Porphyrins: Synthesis,
Structural, Spectral, and Electrochemical Redox Properties . Inorg. Chem. 
2018 , 57 , 11349 –11360 . 10.1021/acs.inorgchem.8b00798 .30179467  e Zatsikha Y. V. ; Schrage B. R. ; Meyer J. ; Nemykin V. N. ; Ziegler C. J. 
1,3-Diylideneisoindolines: Synthesis, Structure, Redox,
and Optical Properties . J. Org. Chem. 
2019 , 84 , 6217 –6222 . 10.1021/acs.joc.9b00468 .31021619 
a Vilches-Herrera M. ; Knepper I. ; de Souza N. ; Villinger A. ; Sosnovskikh V. Y. ; Iaroshenko V. O. 
One-pot,
three-component synthesis of 7-azaindole derivatives from N-substituted
2-amino-4-cyanopyrroles, various aldehydes, and active methylene compounds . ACS Comb. Sci. 
2012 , 14 , 434 –441 . 10.1021/co300042v .22616767  b Khurana J. M. ; Chaudhary A. ; Nand B. ; Lumb A. 
Aqua mediated
indium(III) chloride catalyzed synthesis of fused pyrimidines and
pyrazoles . Tetrahedron Lett. 
2012 , 53 , 3018 –3022 . 10.1016/j.tetlet.2012.04.001 . c Siddiqui Z. N. ; Khan K. 
Friedlander synthesis of novel benzopyranopyridines in the presence
of chitosan as heterogeneous, efficient and biodegradable catalyst
under solvent-free conditions . New J. Chem. 
2013 , 37 , 1595 –1602 . 10.1039/c3nj00069a . d Ray S. ; Brown M. ; Bhaumik A. ; Dutta A. ; Mukhopadhyay C. 
A new MCM-41
supported HPF6 catalyst for the library synthesis of highly substituted
1,4-dihydropyridines and oxidation to pyridines: report of one-dimensional
packing towards LMSOMs and studies on their photophysical properties . Green Chem. 
2013 , 15 , 1910 –1924 . 10.1039/c3gc40441b .
a Zhou Y.-J. ; Chen D.-S. ; Li Y.-L. ; Liu Y. ; Wang X.-S. 
Combinatorial Synthesis of Pyrrolo[3,2-f]quinoline
and Pyrrolo[3,2-a]acridine Derivatives via a Three-Component Reaction
under Catalyst-Free Conditions . ACS Comb. Sci. 
2013 , 15 , 498 –502 . 10.1021/co400073m .23914831  b Chen M. ; Sun N. ; Liu Y. 
Environmentally benign
synthesis of indeno[1,2-b]quinolines via an intramolecular Povarov
reaction . Org. Lett. 
2013 , 15 , 5574 –5577 . 10.1021/ol402775k .24128093  c Allais C. ; Liéby-Muller F. ; Rodriguez J. ; Constantieux T. 
Metal-Free
Michael-Addition-Initiated Three-Component Reaction for the Regioselective
Synthesis of Highly Functionalized Pyridines: Scope, Mechanistic Investigations
and Applications . Eur. J. Org. Chem. 
2013 , 4131 –4145 . 10.1002/ejoc.201300246 . d Marquise N. ; Dorcet V. ; Chevallier F. ; Mongin F. 
Synthesis of substituted azafluorenones from dihalogeno
diaryl ketones by palladium-catalyzed auto-tandem processes . Org. Biomol. Chem. 
2014 , 12 , 8138 –8141 . 10.1039/c4ob01629g .25233952  e Rao Y. ; Liu M. ; Wu L. ; Yin G. 
Catalyst-free one-pot domino reactions for selective synthesis of
functionalized 2,8-oxazabicyclo[3.3.1]-nonanes and 5H-indeno[1,2-b]pyridin-5-ones . RSC Adv. 
2014 , 4 , 64551 –64558 . 10.1039/c4ra13166e .
a Tu S.-J. ; Jiang B. ; Zhang J.-Y. ; Jia R.-H. ; Zhang Y. ; Yao C.-S. 
Efficient and direct
synthesis of poly-substituted indeno[1,2-b]quinolines assisted by
p-toluene sulfonic acid using high-temperature water and microwave
heating via one-pot, three-component reaction . Org. Biomol. Chem. 
2006 , 4 , 3980 –3985 . 10.1039/b611462h .17047879  b Majumder S. ; Sharma M. ; Bhuyan P. J. 
Microwave promoted
diastereoselective synthesis of dihydroindeno[1,2-b]furans via one-pot
three-component reaction in solvent-free conditions . Tetrahedron Lett. 
2013 , 54 , 6868 –6870 . 10.1016/j.tetlet.2013.10.023 . c Ahadi S. ; Moafi L. ; Feiz A. ; Bazgir A. 
Three-component synthesis of new
unsymmetrical oxindoles via Friedel-Crafts type reaction . Tetrahedron 
2011 , 67 , 3954 –3958 . 10.1016/j.tet.2011.02.054 . d Liang B. ; Kalidindi S. ; Porco J. A. ; Stephenson C. R. J. 
Multicomponent
reaction discovery: three-component synthesis of spirooxindoles . Org. Lett. 
2010 , 12 , 572 –575 . 10.1021/ol902764k .20050598 
a Tu S.-J. ; Jiang B. ; Jia R.-H. ; Zhang J.-Y. ; Zhang Y. ; Yao C.-S. ; Shi F. 
An efficient
one-pot, three-component synthesis of indeno[1,2-b]quinoline-9,11(6H,10H)-dione,
acridine-1,8(2H,5H)-dione and quinoline-3-carbonitrile derivatives
from enaminones . Org. Biomol. Chem. 
2006 , 4 , 3664 –3668 . 10.1039/b607575d .16990942  b Ghahremanzadeh R. ; Imani Shakibaei G. ; Ahadi S. ; Bazgir A. 
One-Pot, Pseudo
Four-Component Synthesis of a Spiro[diindeno[1,2-b:2′,1′-e]pyridine-11,3′-indoline]-trione
Library . J. Comb. Chem. 
2010 , 12 , 191 –194 . 10.1021/cc900130a .19863100  c Ghahremanzadeh R. ; Ahadi S. ; Shakibaei G. I. ; Bazgir A. 
Grindstone chemistry:
one-pot synthesis of spiro[diindenopyridine-indoline]triones and spiro[acenaphthylene-diindenopyridine]triones . Tetrahedron Lett. 
2010 , 51 , 499 –502 . 10.1016/j.tetlet.2009.11.041 . d Mondal A. ; Mukhopadhyay C. 
FeCl3-Catalyzed Combinatorial Synthesis
of Functionalized Spiro[Indolo-3,10′-indeno [1,2-b]quinolin]-trione
Derivatives . ACS Comb. Sci. 
2015 , 17 , 404 –408 . 10.1021/acscombsci.5b00038 .26086799  e Mondal A. ; Banerjee B. ; Bhaumik A. ; Mukhopadhyay C. 
Activated
Alumina Balls under Neat Conditions: A Green Catalyst for the Synthesis
of Spiro-Heterocyclic Scaffolds by Ring-Opening versus Annulation
of the Isatin Moiety . ChemCatChem 
2016 , 8 , 1185 –1198 . 10.1002/cctc.201500885 .
a Tugrak M. ; Inci Gul H. ; Sakagami H. ; Gulcin I. ; Supuran C. T. 
New azafluorenones with cytotoxic
and carbonic anhydrase inhibitory properties: 2-Aryl-4-(4-hydroxyphenyl)-5H-indeno[1,2-b]pyridin-5-ones . Bioorg. Chem. 
2018 , 81 , 433 –439 . 10.1016/j.bioorg.2018.09.013 .30223148  b Jangra H. ; Chen Q. ; Fuks E. ; Zenz I. ; Mayer P. ; Ofial A. R. ; Zipse H. ; Mayr H. 
Nucleophilicity
and Electrophilicity Parameters for Predicting Absolute Rate Constants
of Highly Asynchronous 1,3-Dipolar Cycloadditions of Aryldiazomethanes . J. Am. Chem. Soc. 
2018 , 140 , 16758 –16772 . 10.1021/jacs.8b09995 .30444361  c Chen Y.-R. ; Ganapuram M. R. ; Hsieh K.-H. ; Chen K.-H. ; Karanam P. ; Vagh S. S. ; Liou Y.-C. ; Lin W. 
3-Homoacyl coumarin: an all carbon
1,3-dipole for enantioselective concerted (3+2) cycloaddition . Chem. Commun. 
2018 , 54 , 12702 –12705 . 10.1039/c8cc07271j . d Xu H. ; Sha F. ; Li Q. ; Wu X.-Y. 
Catalytic asymmetric Tamura cycloaddition of homophthalic anhydrides
with 2-arylidene-1,3-diones . Org. Biomol. Chem. 
2018 , 16 , 7214 –7222 . 10.1039/c8ob01970c .30255185  e Xu H. ; Chen K. ; Liu H.-W. ; Wang G.-W. 
Solvent-free N-iodosuccinimide-promoted
synthesis of spiroimidazolines from alkenes and amidines under ball-milling
conditions . Org. Chem. Front. 
2018 , 5 , 2864 –2869 . 10.1039/c8qo00723c . f Hussein E. M. ; Moussa Z. ; Ahmed S. A. 
Exclusive regioselective
1,3-dipolar cycloaddition of 9-diazo-9H-fluorene and diphenyldiazomethane
to 2-arylideneindane-1,3-diones: new approach toward effective synthesis
of novel spiropyrazole derivatives . Monatsh.
Chem. 
2018 , 149 , 2021 –2030 . 10.1007/s00706-018-2249-0 .
a Meena K. ; Kumari S. ; Khurana J. M. ; Malik A. 
Efficient syntheses of novel indeno[1,2-b]chromenone derivatives
via hetero-Diels-Alder reactions of 2-(arylmethylene)-1H-indene-1,3(2H)-diones
with enaminones . Tetrahedron Lett. 
2018 , 59 , 1493 –1496 . 10.1016/j.tetlet.2018.03.014 . b Wang M. ; Tang B.-C. ; Xiang J.-C. ; Cheng Y. ; Wang Z.-X. ; Ma J.-T. ; Wu Y.-D. ; Wu A.-X. 
C(sp3)-H
Bond Functionalization of Benzo[c]oxepines via C-O bond Cleavage:
Formal [3+3] Synthesis of Multisubstituted Chromans . J. Org. Chem. 
2018 , 83 , 3409 –3416 . 10.1021/acs.joc.8b00126 .29457901  c Qi J. ; Zheng J. ; Cui S. 
Facile synthesis
of carbo- and heterocycles via Fe(III)-catalyzed alkene hydrofunctionalization . Org. Chem. Front. 
2018 , 5 , 222 –225 . 10.1039/c7qo00817a . d Yu J.-K. ; Chien H.-W. ; Lin Y.-J. ; Karanam P. ; Chen Y.-H. ; Lin W. 
Diversity-oriented synthesis of chromenopyrrolidines
from azomethine ylides and 2-hydroxybenzylidene indandiones via base-controlled
regiodivergent (3+2) cycloaddition . Chem. Commun. 
2018 , 54 , 9921 –9924 . 10.1039/c8cc05693e . e Rapi Z. ; Nemcsok T. ; Grün A. ; Pálvölgyi Á. ; Samu G. ; Hessz D. ; Kubinyi M. ; Kállay M. ; Keglevich G. ; Bakó P. 
Asymmetric cyclopropanation reactions catalyzed by
carbohydrate-based crown ethers . Tetrahedron 
2018 , 74 , 3512 –3526 . 10.1016/j.tet.2018.04.087 .
a Yang S.-M. ; Karanam P. ; Wang M. ; Jang Y.-J. ; Yeh Y.-S. ; Tseng P.-Y. ; Ganapuram M. R. ; Liou Y.-C. ; Lin W. 
A vinylogous Michael addition-triggered
quadruple cascade reaction for the enantioselective generation of
multiple quaternary stereocenters, . Chem. Commun. 
2019 , 55 , 1398 –1401 . 10.1039/c8cc09219b . b Solanke P. ; Pytela O. ; Bureš F. ; Klikar M. 
T-shaped D-π-A-(π-A)2 chromophores with
two auxiliary electron acceptors . Dyes Pigm. 
2019 , 162 , 755 –762 . 10.1016/j.dyepig.2018.10.077 . c Matsuo Y. ; Yu C.-G. ; Nakagawa T. ; Okada H. ; Ueno H. ; Sun T.-G. ; Zhong Y.-W. 
Reduced Knoevenagel
Reaction of Acetetracenylene-1,2-dione with Acceptor Units for Luminescent
Tetracene Derivatives . J. Org. Chem. 
2019 , 84 , 2339 –2345 . 10.1021/acs.joc.8b03083 .30656930 
a Baruah B. ; Bhuyan P. J. 
Synthesis of some
complex pyrano[2,3-b]- and pyrido[2,3-b]quinolines from simple acetanilides
via intramolecular domino hetero Diels-Alder reactions of 1-oxa-1,3-butadienes
in aqueous medium . Tetrahedron 
2009 , 65 , 7099 –7104 . 10.1016/j.tet.2009.06.036 . b Liu J. ; Wang X. ; Sun C.-L. ; Li B.-J. ; Shi Z.-J. ; Wang M. 
New strategy to construct fused/bridged/spiro
carbocyclic scaffolds based on the design of novel 6-C synthon precursor . Org. Biomol. Chem. 
2011 , 9 , 1572 –1577 . 10.1039/c0ob00660b .21240452  c Xu H. ; Sha F. ; Li Q. ; Wu X.-Y. 
Catalytic asymmetric Tamura cycloaddition of homophthalic anhydrides
with 2-arylidene-1,3-diones . Org. Biomol. Chem. 
2018 , 16 , 7214 –7222 . 10.1039/c8ob01970c .30255185 
a Bhuyan D. ; Sarmah M. M. ; Dommaraju Y. ; Prajapati D. 
Microwave-promoted efficient synthesis of spiroindenotetrahydropyridine
derivatives via a catalyst- and solvent-free pseudo one-pot five-component
tandem Knoevenagel/aza-Diels-Alder reaction . Tetrahedron Lett. 
2014 , 55 , 5133 –5136 . 10.1016/j.tetlet.2014.07.086 . b Madhusudhan Reddy G. ; Ko C. T. ; Hsieh K. H. ; Lee C. J. ; Das U. ; Lin W. W. 
Expanding the Scope
of Primary Amine Catalysis: Stereoselective Synthesis of Indanedione-Fused
2,6-Disubstituted trans-Spirocyclohexanones . J. Org. Chem. 
2016 , 81 , 2420 –2431 . 10.1021/acs.joc.5b02921 .26907160  c Xi Q.-Z. ; Gan Z.-J. ; Li E.-Q. ; Duan Z. 
Bronsted Acid
Tuned, Lewis Base Promoted [4+2] Annulation Reactions of Allenoates
with Electron-Deficient Olefins . Eur. J. Org.
Chem. 
2018 , 4917 –4925 . 10.1002/ejoc.201800917 .
a Wang X.-H. ; Yan C. G. 
Facile synthesis
of spiro[indane-2,1′-pyrrolo[2,1-a]isoquinolines] via three-component
reaction of isoquinolinium salts, indane-1,3-dione, and isatins . Synthesis 
2014 , 46 , 1059 –1066 . 10.1055/s-0033-1340815 . b Shi R.-G. ; Wang X.-H. ; Liu R. ; Yan C.-G. 
Two-carbon
ring expansion of isatin: a convenient construction of a dibenzo[b,d]azepinone
scaffold . Chem. Commun. 
2016 , 52 , 6280 –6283 . 10.1039/c6cc00525j . c Jin G. ; Sun J. ; Yan C.-G. 
Formation of zwitterionic salts via
three-component reaction of benzimidazolium bromides, aromatic aldehydes
and 1,3-indanedione . RSC Adv. 
2016 , 6 , 84379 –84387 . 10.1039/c6ra16838h . d Yang W.-J. ; Zhang J. ; Sun J. ; Yan C.-G. 
Convenient
Construction of Indanedione-Fused 2,5-Dihydropyridines, 4,5-Dihydropyridines,
and Spirooxindolines . Eur. J. Org. Chem. 
2016 , 5423 –5428 . 10.1002/ejoc.201600981 . e Shen G. ; Sun J. ; Yan C. 
Convenient Synthesis
of Spiro[benzo[d]pyrrolo[2,1-b]thiazole-3,2′-indenes] Derivatives
via Three-Component Reaction . Chin. J. Chem. 
2016 , 34 , 412 –418 . 10.1002/cjoc.201500896 . f Shi R.-G. ; Sun J. ; Yan C.-G. 
Tandem Double [3+2]
Cycloaddition Reactions at Both C-1 and C-3 Atoms of N-Cyanomethylisoquinolinium
Ylide . ACS Omega 
2017 , 2 , 7820 –7830 . 10.1021/acsomega.7b01391 .31457339  g Liu R. ; Shi R.-G. ; Sun J. ; Yan C.-G. 
A [3+2]-[4+2]-[3+2]
cycloaddition sequence of isoquinolinium ylide . Org. Chem. Front. 
2017 , 4 , 354 –357 . 10.1039/c6qo00615a . h Chen L. ; Sun J. ; Huang Y. ; Yan C. G. 
Regioselectivity
and diastereoselectivity of three-component reaction of α-amino
acid, dialkyl acetylenedicarboxylates and 2-arylidene-1,3-indanediones . Sci. Rep. 
2017 , 7 , 12418 10.1038/s41598-017-12361-z .28963495  i Zhang Y.-Y. ; Han Y. ; Sun J. ; Yan C.-G. 
Construction
of Spiropyrido[2,1-a]isoquinoline via Tandem Reactions of Huisgen’s
1,4-Dipoles with Various Alkene Dipolarophiles . ChemistrySelect 
2017 , 2 , 7382 –7386 . 10.1002/slct.201701348 . j Cao J. ; Sun J. ; Yan C.-G. 
Regioselective and
diastereoselective synthesis of two functionalized 1,5-methanoindeno[1,2-d]azocines
via a three-component reaction . Org. Biomol.
Chem. 
2018 , 16 , 4170 –4175 . 10.1039/c8ob00144h .29786731  k Sun J. ; Sun Q.-S. ; Yan C.-G. 
Selective construction
of indeno[1,2-b]phenothiazine and indeno[2,1-c]phenothiazine via tandem
annulation reaction . Tetrahedron 
2018 , 74 , 2871 –2875 . 10.1016/j.tet.2018.04.062 . l Yang R.-Y. ; Sun J. ; Yan C.-G. 
HOAc-Mediated Domino
Diels-Alder Reaction for Synthesis of Spiro[cyclohexane-1,3′-indolines]
in Ionic Liquid [Bmim] Br. . ACS Omega 
2018 , 3 , 5406 –5416 . 10.1021/acsomega.8b00464 .31458748  m Sun J. ; Zhang Y. ; Shi R.-G. ; Yan C.-G. 
Selective synthesis
of spirooxindoles via a twostep reaction of N-phenacylpyridinium bromide,
1,3-indanedione and N-alkylisations . Org. Biomol.
Chem. 
2019 , 17 , 3978 –3983 . 10.1039/c9ob00166b .30942811 
Yang W.-J. ; Sun Q. ; Sun J. ; Yan C.-G. 
Domino aza/oxa-hetero-Diels–Alder
reaction for construction of novel spiro[pyrido[3′,2′:5,6]pyrano[2,3-d]pyrimidine-7,5′-pyrimidine] . Org. Chem. Front. 
2018 , 5 , 2754 –2758 . 10.1039/c8qo00784e .
Gu R. ; Flidrova K. ; Lehn J.-M. 
Dynamic
Covalent Metathesis in the
C=C/C=N Exchange between Knoevenagel Compounds and Imines . J. Am. Chem. Soc. 
2018 , 140 , 5560 –5568 . 10.1021/jacs.8b01849 .29616806 
Domingo L. R. ; Sáez J. A. 
Understanding the mechanism of polar Diels-Alder reactions . Org. Biomol. Chem. 
2009 , 7 , 3576 –3583 . 10.1039/b909611f .19675915 
a Chu J. C. K. ; Dalton D. M. ; Rovis T. 
Zn-Catalyzed
Enantio- and Diastereoselective Formal [4 + 2] Cycloaddition Involving
Two Electron-Deficient Partners: Asymmetric Synthesis of Piperidines
from 1-Azadienes and Nitro-Alkenes . J. Am. Chem.
Soc. 
2015 , 137 , 4445 –4452 . 10.1021/jacs.5b00033 .25821893  b Neely J. M. ; Rovis T. 
Pyridine synthesis by [4 + 2] cycloadditions
of 1-azadienes: hetero-Diels Alder and transition metal-catalysed
approaches . Org. Chem. Front. 
2014 , 1 , 1010 –1015 . 10.1039/c4qo00187g . c Reddy R. S. ; Lagishetti C. ; Chen S. ; Kiran I. N. C. ; He Y. 
Synthesis of Dihydrophenanthridines and Oxoimidazolidines
from Anilines and Ethylglyoxylate via Aza Diels–Alder Reaction
of Arynes and KF-Induced Annulation . Org. Lett. 
2016 , 18 , 4546 –4549 . 10.1021/acs.orglett.6b02186 .27571345  d Hatanaka Y. ; Nantaku S. ; Nishimura Y. ; Otsuka T. ; Sekikaw T. 
Catalytic enantioselective aza-Diels–Alder
reactions of unactivated acyclic 1,3-dienes with aryl-, alkenyl-,
and alkyl-substituted imines . Chem. Commun. 
2017 , 53 , 8996 –8999 . 10.1039/c7cc03010j .
a Bendale A. R. ; Bhatt R. ; Nagar A. ; Jadhav A. G. ; Vidyasagar G. 
Schiff base synthesis by unconventional
route: an innovative green approach . Der. Pharma.
Chemica. 
2011 , 3 , 34 –38 . b Kaupp G. 
Mechanochemistry: the varied applications
of mechanical bond-breaking . CrystEngComm 
2009 , 11 , 388 –403 . 10.1039/b810822f .
a Barge M. ; Salunkhe R. 
Aqueous extract of
Balanites roxburghii fruit: a green dispersant for C-C bond formation . RSC Adv. 
2014 , 4 , 31177 –31183 . 10.1039/c4ra04387a . b Pati H. N. ; Das U. ; Clercq E. D. ; Balzarini J. ; Dimmock J. R. 
Molecular modifications of 2-arylidene-1-indanones
leading to increased cytotoxic potencies . J.
Enzyme Inhib. Med. Chem. 
2007 , 22 , 37 –42 . 10.1080/14756360600958057 .17373545 
Firouzeh N. ; Hossein K. 
A Green and Highly
Efficient Protocol for Catalyst-free
Knoevenagel Condensation and Michael Addition of Aromatic Aldehydes
with 1,3-Cyclic Diketones in PEG-400 . Chin.
J. Chem. 
2011 , 29 , 2407 –2410 . 10.1002/cjoc.201100005 . b Yu J.-J. ; Wang L.-M. ; Liu J.-Q. ; Guo F.-L. ; Liu Y. ; Jiao N. 
Synthesis of tetraketones in water and under catalyst-free
conditions . Green Chem. 
2010 , 12 , 216 –219 . 10.1039/b913816a .

